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Abstract 
There is evidence to suggest that therapy targeted at normalising extravascular lung water 
volume (EVLW) can improve outcomes from critical illness. Indocyanine green-thermal 
double indicator dilution (ICG-thermal) is considered the clinical reference standard of 
EVLW volume measurement but is no longer commercially available. The accuracy and 
reliability of the only clinically available technology (single-thermal indicator dilution) has 
been questioned in several studies. This thesis incorporates two clinical studies and one 
laboratory study designed to assess the measurement of EVLW and intrathoracic blood 
volumes using a prototype lithium-thermal double indicator dilution technique.   
 
The proof of concept study suggested our hypothesis that intrathoracic blood volume 
(ITBV), which is required for the calculation of EVLW volume, could be determined using 
lithium indicator dilution, was valid. Peri-operative trends and absolute values of ITBV 
were consistent with those obtained using ICG-thermal in a similar patient study group. 
The median absolute value of ITBV measured at baseline using indocyanine green (1417 
[±208] ml) was similar to that obtained using lithium indicator dilution 1542 (±601) ml.  
 
EVLW volume measured by three indicator dilution techniques was then compared to post-
mortem gravimetry in porcine models of acute lung injury. Sepsis and acute lung injury 
were associated with increased EVLW volume, (9.2 [±3.0] ml kg-1), compared to sham 
operated animals (6.6 [±0.45] ml kg-1) in keeping with previous studies. The Li-thermal 
(Bias-1.8 [±13.1] ml kg-1) and ICG-thermal (Bias-1.0 [±6.6] ml kg-1) techniques 
demonstrated acceptable accuracy, but wide limits of agreement suggested poor reliability. 
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The single-thermal technique systematically over-estimated EVLW, with unacceptably 
wide limits of agreement (Bias +8.5 [±14.5] ml kg-1). In this laboratory investigation, the 
double indicator methods appeared more reliable than the single-thermal technique. 
However none could be considered ideal. 
 
Results of the final clinical study suggested EVLW volume measurement in man with the 
Li-thermal method was clearly erroneous (Bias -7.6 [±7.4] ml kg-1) and compared poorly to 
simultaneous measurements made using the ICG-thermal method (Bias +13.2 [±14.4] ml 
kg-1). A considerable over-estimation of mean transit time (MTT) when compared to the 
ICG-thermal technique (Bias 12.8 [±13] sec) was observed, a likely consequence of using 
an external lithium ion electrode instead of an intra-arterial catheter. Manual analysis of the 
dilution curves suggested considerable variability when compared to the automated 
analysis. The poor accuracy of MTT, and consequently ITBV measurements in the clinical 
study, may partly be due to software analysis of the lithium dilution curves. Thoracic blood 
volumes derived from measurement of ICG transit time are reliable. However, EVLW 
calculations based on the thermal indicator transit time are likely to be inaccurate. 
 
The findings of these clinical and laboratory investigations demonstrate poor agreement 
between both the prototype Li-thermal and the single thermal measurements of EVLW 
volume and the ICG-thermal method. Trans-pulmonary lithium indicator dilution 
measurements of ITBV and EVLW volume using an external lithium ion electrode are not 
sufficiently accurate to safely guide clinical interventions in individual patients. 
Consequently we decided not to further develop the lithium-thermal technique of EVLW 
volume measurement. 
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Glossary of terms 
Extravascular lung water volume  
Water within the lung tissue and interstitium but outside of the vasculature. The 
normal range, indexed to body weight, is 3-7mls kg-1. 
 
Intrathoracic blood volume 
The volume of blood within the thoracic cavity. The normal range, indexed to body 
surface area, is 800-1000mls m-2. 
 
Intrathoracic water volume 
 The total volume of fluid, including blood, within the thoracic cavity. 
 
Lithium indicator dilution 
Lithium chloride is injected via a central venous catheter and detected by an 
external sensor attached to a peripheral arterial catheter. The resultant indicator 
dilution curve allows calculation of cardiac output. 
 
Indocyanine green-thermal double indicator dilution 
Cold saline measures total intrathoracic water volume whilst indocyanine green 
binds to plasma proteins allowing measurement of intrathoracic blood volume. 
Calculation of extravascular lung water volume is therefore possible by subtraction.  
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Gravimetry   
Post mortem reference technique of extravascular lung water volume measurement. 
 
Single thermal indicator dilution 
Mathematical analysis of a cold saline indicator curve allows derivation of thoracic 
fluid volumes and extravascular lung water volume. 
 
Mean Transit Time 
 The mean time taken for an indicator to pass from the point of injection to the point 
of detection as measured on the classical indicator dilution curve 
 
LiDCO 
 Trade name of lithium indicator dilution 
 
COLD-Z 
 Trade name of indocyanine green-thermal double indicator dilution 
 
PiCCO 
 Trade name of single-thermal indicator dilution 
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Chapter 1 
Review of the relevant literature 
1.1 Accumulation of extravascular lung water in the critically ill 
The predominant constituent of the lung is water, with the gas exchanging air spaces 
(alveoli) protected by various barriers (alveolar membranes) and fluid drainage (lymphatic 
flow).  There is continuous fluid flux within this system that ensures the alveoli remain 
clear of fluid thereby allowing efficient gas exchange. Consequently there is always an 
amount of water within the lung interstitium. Whilst in the normal range of 3 to 7 ml kg-1 
(water content of the pulmonary interstitium),1 this fluid is of minor significance to the 
patient or attending physician. As these protective mechanisms of the lung begin to fail 
either through injury, increased vascular pressures or both, the amount of fluid within the 
interstitium increases, termed interstitial oedema. When these compensatory mechanisms 
are overwhelmed there is sudden catastrophic movement of fluid into the alveoli by a more 
rapid process termed alveolar flooding.2 This is more commonly known as pulmonary 
oedema with physiological impairment becoming apparent when the lung water volume 
exceeds 10 ml kg-1 (Table 1.1).3-13 Both interstitial oedema and pulmonary oedema are 
therefore terms that can be used to describe the accumulation of extravascular lung water 
(EVLW). 
Pulmonary oedema is a common and serious clinical feature of a wide range of medical 
conditions and can pose a considerable clinical problem, such that mechanical ventilation 
may be required. It may result from an increase in pulmonary capillary permeability (acute 
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lung injury, ALI) or from an increase in pulmonary capillary pressure (hydrostatic or 
cardiogenic pulmonary oedema).14 Resolution of pulmonary oedema depends on the active 
removal of salt and water from the distal air spaces across the lung epithelial barrier,15 a 
mechanism frequently impaired in cases of lung injury.16 
  
Authors Ref Type of Oedema EVLW )ml kg
-1, 
(Mean ± SD 
Dilution Method
Slutsky and Brown13 Cardiogenic (chronic) 16.3 ± 1.8 Double indicator 
 Cardiogenic (acute) 10.7 ± 1.3 Double indicator 
Bindels et al3 Cardiogenic 13.7 ± 1.5 Double indicator 
Sibbald et al.12 Cardiogenic 10.2 ± 3.1 Double indicator 
 ALI/ARDS 15.8 ± 4.6 Double indicator 
Sibbald et al.11 Cardiogenic 9.3 ± 3 Double indicator 
 ALI/ARDS 14.5 ± 4.9 Double indicator 
McAuley et al7 ALI/ARDS 14.2 Single indicator 
Boussat et al4 ALI/ARDS 17.3 ± 8 Double indicator 
Michard et al8 ALI/ARDS 11.3 ± 5.4 Single indicator 
Martin et al6 ARDS 15 Single indicator 
Michelet et al9 ARDS 11.2 ± 6.0 Double indicator 
Patroniti et al10 ARDS 12.3 ± 3.4 Double indicator 
Groeneveld and Verheij5 ALI (pneumonia) 9 Double indicator 
 ALI (extrapulmonary) 7.8 Double indicator 
 
Table 1.1 Reported values for extravascular lung water (EVLW) in patients with cardiogenic 
pulmonary oedema and in patients with acute lung injury (ALI) or acute respiratory distress syndrome 
(ARDS) 
 
The clinical features of pulmonary oedema include hypoxemia and dyspnoea, along with 
those of the associated underlying medical condition. Diagnosis and recognition of 
pulmonary oedema or increased extravascular lung water volume is generally based on 
subjective clinical criteria including history, respiratory rate, jugular venous pressure and 
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auscultation of the chest combined with chest radiography. However, clinical assessment of 
the extent and severity of pulmonary capillary leak and EVLW accumulation is often 
difficult and inconsistent, particularly in critically ill patients and those who are 
mechanically ventilated. Evidence suggests that neither impaired oxygenation, nor chest 
radiographic appearances provide a reliable indication of EVLW volume.17-21 Traditional 
methods of reducing EVLW volume include the use of loop diuretics and vasodilator 
drugs.22 Such treatment is usually coupled with oxygen therapy with or without continuous 
positive airway pressure (CPAP) or mechanical ventilation with positive end-expiratory 
pressure (PEEP) to relieve respiratory distress and improve arterial oxygen partial pressure 
(PaO2).23,24 The choice of these interventions is very much at the discretion of the clinician. 
Pharmacological therapy is titrated to achieve subjective clinical improvement with 
associated recovery of the PaO2 to normal or above normal limits, rather than aiming for a 
quantitative EVLW volume target. The critically ill patient may often also require fluid 
resuscitation to correct hypovolaemia and maintain oxygen delivery to the major organs.  
However, in the presence of increased pulmonary capillary permeability or impaired 
myocardial function, the administration of large volumes of intravenous fluid may be 
associated with a significant increase in EVLW volume thereby worsening the overall 
condition of the patient. Effective fluid resuscitation involves a fine balance between the 
consequences of excessive EVLW volume and inadequate tissue oxygen delivery, both of 
which may result in poor outcome.25,26 However there is some evidence to suggest that 
fluid restriction can positively influence the course of illness and improve the outcome of 
patients with Acute Respiratory Distress Syndrome (ARDS).27 Thus, balancing optimal 
cardiac preload and circulating volume with intravenous fluid therapy against the threat of 
worsening pulmonary oedema is a clinical dilemma that requires reliable monitoring tools. 
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1.2 Clinical relevance of extravascular lung water volume measurement 
In a large retrospective analysis of 373 critically ill patients, the mortality rate was 
approximately 65% in patients with EVLW volume greater than 15 ml kg-1, compared to 
approximately 33% in patients with EVLW volume less than 10 ml kg-1 i.e. patients with 
pulmonary versus interstitial oedema.28  Univariate logistic regression analysis of this data 
demonstrated EVLW at baseline as well as simplified acute physiology score (SAPS) II and 
acute physiology and chronic health evaluation (APACHE) II scores (r2=0.05, p<0.0001) 
were all significant predictors of mortality. The authors further analysed SAPS II and 
APACHE II scores. Combination of SAPS II and APACHE II scores increased r2 to 0.136, 
but the improvement over SAPS II alone was not significant. The addition of baseline 
EVLW further increased r2 to 0.149 (p=0.021 for the improvement), suggesting that EVLW 
contributes independently to prognosis. Three randomised control trials have investigated 
the use of EVLW volume to guide treatment. Fluid and diuretic therapy guided by EVLW 
volume, when compared to pulmonary artery occlusion, resulted in a reduction in the 
duration of invasive ventilation, a less positive fluid balance and shorter ICU stay.29 
Moreover the use of EVLW volume measurement to guide clinical management during 
critical illness showed reduction in the duration of mechanical ventilation and intensive 
care unit stay.26,30 
 
1.3 Importance of EVLW volume measurement 
A recent multicentre randomised trial 31 conducted in patients with acute lung injury 
demonstrated that fluid restriction and diuresis improved lung function and shortened the 
duration of mechanical ventilation and intensive care stay. Despite EVLW volume not 
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being targeted in this trial the results emphasise the potential value of EVLW measurement 
as a tool to guide such a therapeutic strategy.2,32 This is consistent with the considerable 
body of evidence highlighting improved outcome, reduced ventilator and ICU days with 
EVLW targeted therapy.26,28-30 In the current NHS economic climate, where cost 
effectiveness as well as quality of care is important, providing EVLW volume monitoring 
in all critically ill patients using reliable technology could be considered a routine standard 
of care. As there is some uncertainty surrounding the validity of the technology currently 
available for this purpose, it seems logical to seek a reliable, user friendly technique to 
accurately measure these thoracic fluid volumes.  
 
1.4 Gravimetric technique of extravascular lung water volume 
measurement 
The gravimetric technique of EVLW volume measurement is a laboratory research tool first 
described by Hemingway in 1950 33 and later adapted by Pearce.34 This method was used 
by several groups in the 1950’s and 60’s to examine the physiology, pharmacology and 
measurement of pulmonary oedema.33-35 EVLW is calculated from a number of 
measurements, as described in section 2.4, allowing estimation of the wet:dry mass ratio of 
the lung. Whilst the gravimetric technique remains the reference standard to which new 
techniques should be compared, this method is limited by its complexity and the fact that 
only a single, post-mortem measurement can be made on any given subject. 
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1.5 Indicator dilution techniques of extravascular lung water volume 
measurement 
The indicator dilution technique was originally developed as a method for measuring 
cardiac output. The most significant contributions to our understanding of this technique for 
the measurement of extravascular lung water were made in the 1920’s by Stewart and 
Hamilton (see section 1.5.1.1).36,37 In 1955, the first measurements of pulmonary blood 
volume (PBV) in man were performed by Kunieda and Fujimoto using sequential 
injections of Evans blue dye.38 This work was subsequently repeated using other indicators 
including indocyanine green and radio-iodinated human serum albumin.39-41 The double 
indicator dilution method of EVLW volume measurement was first performed using a 
radioisotope by Chinard in a series of experiments in the 1950s.42 Subtraction of 
intrathoracic blood volume (ITBV), measured by one non-diffusible intravascular indicator, 
from total intrathoracic water volume (ITWV) measured by another which freely diffuses 
out of the vascular compartment, allows derivation of EVLW volume (see equation 1.1). 
This work eventually led to the development of a bedside technique which was introduced 
into clinical practice in the 1980’s. 
 
ITBVITWVEVLW −=  
 
Equation 1.1 Derivation of extravascular lung water volume 
EVLW, Extravascular lung water; ITBV, Intrathoracic blood volume; ITWV, Intrathoracic water volume 
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1.5.1 Principles of indicator dilution 
The perfect indicator would be stable, non-toxic and easily measured. It would distribute 
uniformly throughout the physiological compartment under investigation but not be lost 
from the system of interest during passage from the point of injection to the site of 
detection. It would then dissipate rapidly to avoid any error resulting from recirculation. 
For the purposes of thoracic volume measurements, the most important criteria may 
include: 
 
1. Motion of the indicator is representative of the motion of the test fluid 
2. Indicator volume is small enough not to alter the distribution of the test fluid 
3. The indicator completely leaves the test system 
4. Flow of the test fluid is constant during the period of evaluation 
5. The whole test compartment is in a dynamic equilibrium allowing the indicator to 
penetrate the entire compartment and leave within the duration of a single 
circulation 
 
Perhaps not surprisingly, the perfect indicator does not exist although a number of different 
substances have been used for this purpose. The most common practical disadvantages 
include poor stability, difficulties with measurement of indicator concentration and 
recirculation or accumulation. Although the difficulties with recirculation may be overcome 
by extrapolation of the concentration-time curve (Figure 1.1), accumulation of the indicator 
usually limits the maximum number of accurate measurements. Consequently, most 
indicators are only suitable for laboratory studies. 
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Figure 1.1 Relationship between concentration and time for an indicator injected as a bolus into a 
central vein and measured in a major artery  
Top figure illustrates indicator recirculation. Bottom figure is the natural logarithm of the top curve extrapolated at the point the curve 
becomes exponential. MTt, mean transit time; DSt, downslope time 
 
There are two principles of indicator dilution which are particularly relevant to the 
measurement of all thoracic fluid volumes especially EVLW volume, ITBV, ITWV and 
PBV, namely the Stewart-Hamilton and Newman hypotheses. 
1.5.1.1  Stewart-Hamilton hypothesis 
The first principle of thoracic fluid measurement using indicator dilution was formulated by 
Stewart in 1921 who performed a series of experiments using a hypertonic saline 
indicator.37 As blood flowed past the sampling point, the change in electrical conductance 
of blood generated a detectable output signal. These studies allowed Stewart to identify and 
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describe the relationship between cardiac output, the volume throughout which an indicator 
is distributed, and the mean time taken for the indicator to pass from the point of injection 
to the point of detection (mean transit time, equation 1.2).  
 
COxMTTV =  
Equation 1.2 Stewart hypothesis  
V, the volume throughout which an indicator is distributed; CO, cardiac output; MTT,  mean time taken for the indicator to pass from the 
point of injection to the point of detection (mean transit time) 
 
Hamilton subsequently developed the principles described by Stewart to allow the 
measurement of cardiac output using the indicator dilution technique to generate an arterial 
dye concentration versus time curve (Fig. 1.1).36 Cardiac output was shown to be inversely 
proportional to the area under the curve (equation 1.3). The great importance of the work of 
Stewart and Hamilton relates to the use of the principles they described in many of the best 
known clinical methods of cardiac output measurement. 
 
∫= dttCQM ).(  
Equation 1.3 Stewart-Hamilton hypothesis  
If an indicator is injected rapidly into the right atrium, it will appear downstream in the pulmonary artery in a concentration that varies 
with time, C(t). As all the injected indicator (M) must leave the system, M is equal to the sum of the concentrations at each interval (t) 
multiplied by flow (Q), which is assumed to be constant. 
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1.5.1.2  Newman Hypothesis 
The second principle of thoracic fluid measurement using indicator dilution was described 
by Newman in 1951 and explains the relationship between cardiac output, the volume of 
the largest chamber (C) in the path of the indicator and the decay curve rate constant of the 
semi-logarithmic plot of indicator concentration against time. This has also been termed the 
downslope time (DSt) (equation 1.4).43 
DSt
COC =  
Equation 1.4 Newman Hypothesis  
C, the volume of the largest chamber  in the path of the indicator; CO, cardiac output; DSt,  rate constant of the decay curve of the semi-
logarithmic plot of indicator concentration against time, which has also been termed downslope time 
 
These principles illustrate the fact that the conformation of the trans-pulmonary indicator 
dilution curve is influenced by the various intra-thoracic compartments (Figure 1.2). The 
volume of some of these compartments may therefore be estimated through the use of 
indicators with different properties. 
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LVEDVLAEDVPBVRVEDVRAEDVITBV ++++=  
 
LVEDVLAEDVRVEDVRAEDVGEDV +++=  
 
ITBVITWVEVLW −=  
 
 
Figure 1.2 Relationship between the intra-thoracic compartments which influence measurements taken 
from the trans-pulmonary indicator dilution curve 
RAEDV, right atrial end-diastolic Volume; RVEDV, right ventricular end-diastolic volume; PWV, pulmonary water volume;  PBV, 
pulmonary blood volume; LAEDV, left atrial end-diastolic volume; LVEDV, left ventricular end-diastolic volume; EVLW, extravascular 
lung water volume; ITWV, intrathoracic water volume; ITBV, intrathoracic blood volume; GEDV, global  end diastolic blood volume 
RAEDV LVEDV RVEDV LAEDV PBV 
EVLW
EVLW
ITWV 
PWV
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1.5.2 Double indicator dilution techniques 
Although this technique has been performed with various pairs of indicators, the general 
principle is the same with each. One indicator should diffuse into and out of the thoracic 
water compartment within the duration of one circulation time. In clinical practice, a cold 
saline thermal indicator is generally used for this purpose. The second indicator must 
distribute throughout the ITBV compartment but not diffuse into the ITWV compartment.  
 
 
Figure 1.3 Derivation of EVLW using double indicator dilution 
EVLW, extravascular lung water volume; ITWV, intrathoracic water volume; ITBV, intrathoracic blood volume  
 
In most cases this indicator is non-diffusible because of strong plasma protein binding e.g. 
indocyanine green. Both indicators should be injected simultaneously to avoid any error 
due to alterations in cardiac output. According to Stewart’s equation, the difference in mean 
= _
EVLW= ITWV-ITBV
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transit time (MTT) of the two indicators will allow estimation of the difference in 
distribution volumes which in turn represents EVLW volume (equation 1.5). 
)( diffNonThermal MTTMTTCOxEVLW −−=  
Equation 1.5 EVLW calculated using differences in MTT  
EVLW, extravascular lung water volume; CO, cardiac output; MTTthermal, Mean transit time of thermal indicator; MTTnon-diff, Mean transit 
time of non-diffusible indicator 
 
The most widely used double indicator method of EVLW volume measurement is the 
indocyanine green-thermal double indicator dilution (ICG-thermal) technique. A major 
assumption is made that the thermal indicator, normally ice cold saline, diffuses completely 
throughout the pulmonary and intrathoracic water volumes and is equal to the thermal 
volumes measured by this method. Measurements made using this technique appear to 
correlate well with those made using the gravimetric method in dogs.44,45 In a study of nine 
human organ donors, the ICG-thermal double indicator dilution technique was compared to 
gravimetric studies with good agreement between the two techniques, although one subject 
was excluded because the ICG-thermal double indicator dilution technique grossly 
underestimated EVLW volume (figure 1.4).46  Subsequent macroscopic examination 
revealed significant acute lung injury in this patient. 
 
In a more detailed study, Roch et al compared the ICG-thermal method to gravimetry in a 
pig model of direct and indirect acute lung injury.47 The methods compared well in the 
animals with indirect acute lung injury. However in the direct injury model the ICG-
thermal method underestimated EVLW volume, especially at higher volumes. 
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Figure 1.4 Relationship between ICG-thermal double indicator dilution technique measurements of 
EVLW and those made by gravimetry in human organ donors (r2=0.95,  p<0.001). From Mihm FG, et al.46   
EVLW, extravascular lung water volume 
 
In another study using a porcine model of endotoxin induced lung injury, a similar double 
indicator dilution technique was compared with gravimetric measurements.48 In this study, 
a deuterium oxide (2H2O) indicator was used in preference to cold saline whilst 
indocyanine green was used as the non-diffusible indicator. Once again findings suggested 
a good correlation under baseline conditions. However, the double indicator dilution 
technique underestimated EVLW volume at higher values when compared to the 
gravimetric reference method.  
 
It therefore seems that the indocyanine green-thermal double indicator dilution technique 
consistently underestimates EVLW volume at higher values, as might be the case for 
example, in patients with acute lung injury. This underestimation may be explained by 
redistribution of pulmonary blood flow away from areas in which alveoli are flooded 
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thereby limiting indicator diffusion and the detection of oedema in these regions during just 
one trans-pulmonary transit. 47-50 Positive end-expiratory pressure (PEEP) during 
mechanical ventilation may also be associated with an underestimation of EVLW volume.51 
In addition, studies have suggested that underestimation of EVLW by ICG-thermal dilution 
may be more frequent at higher cardiac output 52,53, although these findings may be 
explained by technical problems with specific devices.54  
 
Devices have been produced commercially that allow indocyanine green-thermal double 
indicator dilution measurements at the bedside. Despite yielding EVLW volume figures 
with good reproducibility 55, the clinical use of this equipment has proved unpopular, not 
least because of the financial cost of indocyanine green, and the technical difficulty 
acquiring reliable ICG indicator dilution curves. These monitors have now been withdrawn 
from production, although consumables are still available on a limited basis for one device 
(COLD-Z, Pulsion Medical Systems, figure 1.5).  
 
Figure 1.5 COLD-Z, Pulsion Medical Systems, Munich, Germany 
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1.5.3 Single indicator dilution techniques 
Currently the only commercially available method of EVLW volume measurement is the 
trans-pulmonary (single) thermal indicator technique (PiCCO, Pulsion Medical Systems, 
Munich, Germany, see figure 1.6). Estimation of EVLW by this technique was first 
proposed around 25 years ago.56,57 Intrathoracic thermal volume is calculated using a cold 
saline indicator in an identical fashion to the double indicator dilution technique described 
above. However, rather than using a second non-diffusible indicator to measure ITBV, this 
value is calculated by using additional mathematical analysis of the thermal indicator 
dilution curve. By applying the principle described by Newman 43, it is possible to calculate 
the volume of the single largest mixing chamber traversed by an indicator, in this case,  the 
pulmonary water volume. By subtracting pulmonary water volume from intra-thoracic 
water volume, global end diastolic volume (GEDV) may be calculated. An important 
assumption is then made that there is a constant relationship between ITBV and GEDV that 
can then be used to derive EVLW. 58 
 
Figure 1.6 PiCCO, Pulsion Medical Systems, Munich, Germany 
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This relationship was derived following structural regression analysis of the first two ICG-
thermal dilution measurements in a derivation population of 57 critically ill patients that 
had suggested a constant relationship between ITBV and GEDV (ITBV = 1.25 x GEDV-
28.4). An early study of the trans-pulmonary single thermal versus the indocyanine green-
thermal double indicator dilution techniques suggested very poor correlation.59 A total of 
84 comparisons in 18 patients demonstrated that the single-thermal technique significantly 
over-estimated EVLW volume when compared to the ICG-thermal technique (p<0.05).  
However, a subsequent study in a population of 209 critically ill patients, suggested 
reasonable agreement between the corresponding values of ITBV and EVLW volume using 
the two methods. Single-thermodilution ITBV (ITBVsingle) and EVLW (EVLWsingle) were 
calculated and compared to the ICG-thermal dilution derived values (ITBVICG-thermal & 
EVLWICG-thermal). Linear regression analysis yielded a correlation of ITBVsingle=1.05 x 
ITBVICG-thermal -58.0ml m-2 (r=0.97, p< 0.0001). EVLWsingle was calculated using ITBVsingle 
and revealed the correlation EVLWsingle = 0.83 x EVLWICG-thermal + 1.6ml kg-1 (r=0.96, p < 
0.0001). The authors noted that the single-thermal method over-estimated EVLW at low 
EVLWICG-thermal volume and underestimated EVLW at values greater than 12ml kg-1. 58  
  
There are several potential sources of error associated with this single thermal indicator 
approach to EVLW volume measurement. In common with the indocyanine green-thermal 
double indicator dilution technique, equilibration between the temperature of the saline 
bolus and body temperature may result in significant loss of indicator along the pathway 
between the injection point in the superior vena cava and the measurement point in the 
femoral artery thereby reducing the signal amplitude. Moreover, because the tip of the 
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femoral artery catheter is not placed at the level of the diaphragm, part or all of the volume 
of the abdominal aorta will be included in the measurement. This results in a falsely high 
estimate of ITBV and therefore a falsely low value for EVLW volume. Also, because a 
thermal indicator will not equilibrate fully with flooded alveoli in one trans-pulmonary 
circulation, it is likely that high EVLW volumes will be underestimated with this technique. 
The assumption that the relationship between GEDV and ITBV is constant, regardless of 
clinical circumstances, is also questionable. Although some studies support the existence of 
a relationship between these two variables, there is evidence that it is affected by changes in 
cardiac output and circulating volume.60-62  
 
Three studies have compared the trans-pulmonary single thermal indicator dilution 
technique to the gravimetric method  and all suggested a reasonable correlation between the 
two methods.61,63,64 However, trans-pulmonary single thermal indicator dilution 
consistently overestimates EVLW volume when compared to the gravimetric method. 
Rossi et al identified considerable bias and wide limits of agreement (5.4 ml kg-1, LOA 
±2.8) between the two techniques in a porcine model of endotoxin induced acute lung 
injury. The authors suggested that the accuracy of the single thermal technique could be 
improved by adjusting the algorithm so that ITBV=1.52GEDV +49.7.61 Similar problems 
were observed in a study by Kirov et al in an oleic acid model of acute lung injury in sheep. 
They too reported significant bias and limits of agreement (4.9 ml kg-1 ±5.1) despite using 
data derived from a modified algorithm, ITBV=1.34GEDV.64 
 
A number of studies suggest that the accuracy of EVLW volume estimation by the single 
thermal indicator technique could be improved by revising the mathematical relationship 
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between ITBV and GEDV.60-62 Michard et al evaluated a range of clinical factors that 
might influence EVLW volume measurements made by trans-pulmonary single thermal 
indicator dilution.65 When compared with the indocyanine green-thermal double indicator 
dilution technique, the reliability of measurements was not affected by height, weight, 
cardiac output or the dose of vasoactive agents. However, PaO2:FiO2 ratio, tidal volume 
and PEEP significantly affected the agreement between the two techniques in the 
measurement of EVLW volume.  
 
Although trans-pulmonary thermal single indicator dilution is a practical bedside method of 
EVLW volume measurement, there is considerable doubt over the accuracy of EVLW 
volume measurement by this method.66 Nevertheless EVLW volume determined using this 
method does appear to have prognostic significance.6,25  
 
1.6 Determination of extravascular lung water using imaging techniques 
1.6.1 Chest radiography 
Pulmonary oedema is normally diagnosed by clinical examination and chest radiography. 
The classical appearance of cardiogenic pulmonary oedema is bilateral diffuse pulmonary 
infiltrates, with upper lobe blood diversion and air bronchograms (figure 1.7) which can be 
difficult to distinguish from non-cardiogenic pulmonary oedema or acute lung injury 
(figure 1.8). Some studies have identified a group of patients in whom chest radiographs are 
abnormal but lung water measurements are within the normal range, illustrating the 
difficulty in distinguishing excess lung water from pulmonary infiltrates due to other causes 
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or regions of atelectasis.20 Halperin et al. evaluated the portable chest radiograph against 
the ICG-thermal technique in twelve patients admitted to intensive care with a diagnosis of 
respiratory failure.17 They concluded that the chest radiograph allowed diagnosis of 
excessive EVLW but only when EVLW volume reached a threshold of 35% above normal. 
However, the absence of any signs of pulmonary oedema on the chest radiograph almost 
ruled out excessive EVLW volume. A similar study by Laggner et al. evaluated EVLW 
volume estimation in fifty three critically ill patients by the chest radiograph in comparison 
to the ICG-thermal technique.19 They found reasonable agreement between the two 
methods (r = 0.83, p < 0.001). Nevertheless, even as a non-quantitative method, the chest 
radiograph remains an unreliable indicator of the presence of pulmonary oedema largely 
because interpretation is influenced by a range of confounding factors.18 
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Figure 1.7 Chest radiograph showing cardiogenic pulmonary oedema 
 
 
 
Figure 1.8 Chest radiograph showing non-cardiogenic pulmonary oedema in a patient with acute lung 
injury 
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1.6.2 Computed tomography (CT) 
Whilst computed tomography can generate excellent images of thoracic structures, the 
quantification of EVLW volume is more difficult because the associated changes are non-
specific. The computation of gas and tissue lung volumes from CT densities is based on 
several assumptions: 
 
1.  A linear correlation between physical density and attenuation of electromagnetic 
radiation. 
2. The approximation of the physical density of non-aerated lung tissue (including 
lung parenchyma, blood, and water) to the physical density of water.  
3. Any nominal CT volume unit identified in the lung consists only of gas and lung 
tissue as opposed to infective cellular debris, pus, etc. 
 
In a small study of patients with acute lung injury, quantitative computed tomography 
measurements of lung oedema appeared to correlate well with those made using the ICG-
thermal technique.67 Fourteen mechanically ventilated patients with acute respiratory 
distress syndrome underwent a spiral CT of the thorax.  Pulmonary thermal volume (PTV), 
EVLW and pulmonary blood volume (PBV) were measured with the indocyanine green-
thermal double indicator dilution method. EVLW volume correlated well with lung weight 
measured by CT (R=0.91, p < .0001).  Unfortunately, because of the risks associated with 
radiation exposure and transfer of critically ill patients, in addition to financial costs and 
limited availability, it is impractical to make repeated EVLW volume measurements by CT. 
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1.6.3 Magnetic Resonance Imaging (MRI) 
MRI allows detailed three-dimensional imaging of tissue without the use of ionizing 
radiation. Knowledge of the signal produced by proton density and T1 weighted images 
allows calculation of the relative proton density within tissue. Because lung parenchyma 
contains insignificant amounts of fat and other hydrogen-bound complexes, the proton 
density measured by MRI principally reflects water content. Early attempts at proton MRI 
of the adult lung proved challenging. The low proton density of the lung resulted in a poor 
signal, whilst blood flow, cardiac pulsation and respiration caused considerable artefact. 
However, recent improvements in MRI technology have allowed more rapid image 
acquisition and electrocardiograph-respiratory gating. This allows co-ordination of 
stationary image capture within the cardiac and respiratory cycles with a substantial 
improvement in the clarity of the images acquired. MRI may therefore be used in the 
assessment of a variety of lung conditions including pulmonary oedema.68 Qualitative and 
quantitative assessments of lung water content have been performed using MRI in both the 
normal adult lung 69,70 and animal models of pulmonary oedema, where comparisons have 
been made with the gravimetric technique.71 The use of contrast agents has allowed 
measurement of total intravascular volume and the simultaneous determination of total lung 
water using a multi-spin-echo sequence. This provides a measurement of EVLW volume 
which correlates well with the gravimetric technique.72  
 
An alternative approach to the radiological imaging of lung water is the use of sodium 
MRI.73 This approach utilizes the distribution of sodium ions to quantify EVLW. The 
concentration of sodium ions in extracellular fluid is greater than ten times that of 
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intracellular fluid. The majority of sodium ions within the lung will therefore be situated 
within plasma, the interstitium or the alveoli. The use of contrast agents allows the plasma 
signal to be suppressed. Generation of an extravascular lung sodium image is then possible 
and this indicates the presence and distribution of EVLW. The signal intensity appears to 
correlate well with EVLW volume measured by the gravimetric method.73 However, at 
present it seems unlikely that either sodium MRI or the more basic MRI assessment of 
pulmonary oedema will be integrated into routine clinical practice for similar reasons to 
those already mentioned with regard to CT scanning.  
 
1.6.4 Ultrasonography  
Ultrasonography is considered a poor technique for imaging the lung because ultrasound 
waves are reflected by air within the lung, creating reverberation artefact.74 Nevertheless, 
this technology can be used to provide an indication of lung water content. The ‘comet-tail’ 
is a form of artefact which arises when there is a marked difference in acoustic impedance 
between an object and its surroundings.75 In the presence of increased EVLW volume, the 
comet-tail sign may be seen to originate from water-thickened interlobular septa and fan 
out across the lung surface. This sign may be detected with either radiological or cardiac 
ultrasound equipment (figure 1.9a). 
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Figure 1.9a Typical comet tail artefacts as seen 
by ultrasound demonstrating increased 
extravascular lung water 
Figure 1.9b Normal subject, with regular, 
parallel, roughly horizontal hyperechogenic 
lines due to the lung-chest wall interface
  
In one study of critically ill patients, multiple comet-tail artefacts were identified by 
ultrasonography of the lungs in eighty-six out of ninety-two patients with radiographic 
evidence of acute lung injury, cardiogenic pulmonary oedema, or exacerbation of chronic 
interstitial lung disease.76 A smaller study of twenty cardiac surgical patients demonstrated 
that there was a positive linear correlation between the comet-tail score and EVLW volume 
determined by trans-pulmonary thermal indicator dilution, as well as pulmonary artery 
occlusion pressure and chest radiograph lung water score.77 Further work suggested that the 
comet-tail score has a linear relationship with a radiographic extravascular lung water 
volume score 78 and may be useful in distinguishing pulmonary oedema from other forms 
of lung disease.79 However, whilst chest ultrasound may be a simple and quick method of 
EVLW volume assessment, this approach does not appear to have any advantage over chest 
radiography in terms of diagnostic accuracy, but does allow differentiation of other lung 
pathologies, for example, pleural effusion and consolidated lung tissue. 
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1.6.5 Ultrasound velocity and electrical impedance dilution  
Krivitski et al described a novel technique whereby EVLW volume may be estimated by 
ultrasonographic blood velocity measurement and electrical impedance dilution.80,81 In an 
animal study, changes in systemic arterial sound velocity and electrical impedance during 
the intravenous injection of hypertonic and isotonic sodium chloride solution were used to 
calculate lung permeability and provide an estimate of EVLW volume.80 These 
measurements were comparable to those made using the gravimetric technique. This 
technique has also been used to monitor changes in EVLW volume during haemodialysis.81 
Although the indexed measurements were similar to those from the animal study, they do 
not seem to be consistent with clinical changes associated with haemodialysis.  
1.6.6 Positron Emission Tomography (PET)  
PET is a nuclear imaging technique that involves the use of radioactive isotope markers 
which emit positrons during the process of spontaneous decay. Emitted positrons, having 
annihilated electrons, produce gamma rays which are emitted and detected to generate a 
three-dimensional image. Continuous intravenous infusion of water labelled with O15 and 
subsequent inhalation of C11 labelled carbon monoxide allows the quantitative 
measurement of total thoracic water and ITBV. EVLW volume is then determined by 
subtraction. This technique correlates well with both the indocyanine green-thermal double 
indicator dilution and gravimetric techniques in dogs.82 
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1.7 Measurement of extravascular lung water using other techniques 
1.7.1 Dual-isotope technique  
Iodine131 labelled iodo-antipyrine and 99mTc labelled erythrocytes have been used to 
measure EVLW volume in rabbits with acute lung injury.83 These radioactive tracers were 
injected into 10 rabbits with normal lungs and 11 rabbits with injured lungs. Blood samples 
were drawn and the animals were sacrificed. The lungs were removed, weighed and 
homogenized for gravimetric analysis. Samples of blood and lung homogenate were also 
assayed for 131I and 99mTc. Extravascular lung water volume measurement determined by 
the dual isotope technique correlated well the gravimetric method but appears to be 
restricted to the research setting. 
1.7.2 Impedance plethysmography  
Attempts have been made to monitor changes in intrathoracic blood volume and 
extravascular lung water volume by impedance plethysmography. Accumulation of lung 
water leads to a decrease in internal thoracic impedance, which is measured non-invasively 
using cutaneous electrodes placed over the right lung.84 Internal thoracic impedance can 
decrease by as much as 12% before clinical signs become apparent. This technique has 
been successfully used to anticipate the onset of clinically evident pulmonary oedema by 
between 30 and 60 minutes. This technique however does not allow quantification of 
EVLW volume and appears to only detect alveolar flooding, not interstitial oedema. 
Consequently it would be of minimal benefit to the critical care physician in guiding 
therapeutic interventions designed to reduce EVLW volume. 
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1.8 Discussion 
Increased extravascular lung water volume is a recognised feature of critical illness, in 
particular acute lung injury. Increased extravascular lung water volume has been identified 
in critically ill patients with acute lung injury using a variety of indicator dilution 
techniques.4-6,8,10,25 The research and indicator dilution clinical reference methods for 
EVLW volume measurement, namely the gravimetric and ICG-thermal techniques, are 
either not suitable, or not commercially available for clinical use. The variety of imaging 
techniques discussed in this chapter are either impractical for repeated measurements (CT, 
MRI & PET scanning) or provide non-quantitative information (chest radiography or 
ultrasonography). Alternative methodologies are restricted to the research environment 
(dual-isotopes) or are not sufficiently precise (impedance plethysmography). The only 
commercially available practical device for measuring EVLW volume at the bedside is the 
single-thermal indicator dilution technique (PiCCO®, Pulsion Medical Systems, Munich, 
Germany). The accuracy and validity of this method may be affected by number of 
common confounders.60-62,64 Indeed, a recent study investigating the use of salbutamol 
infusions to control EVLW volume, was criticised because single-thermal indicator dilution 
technology was employed to measure EVLW volume.85,86 
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1.9 Hypothesis 
A possible solution to the need to measure EVLW volume could be trans-pulmonary 
lithium indicator dilution. By combining this measurement with thermodilution, EVLW 
volume could be calculated without relying on the assumptions made when using 
thermodilution alone. There are several reasons why this could be a more practical and 
reliable approach than previously described technologies. Lithium chloride appears to 
satisfy many criteria for an ideal indicator to measure a vascular compartment (see page 
25), principally because it remains within the vasculature during one trans-pulmonary 
circulation time.87-89 This indicator has been incorporated into a commercially available 
device for cardiac output monitoring developed by LiDCO™  (LiDCOplus™ version 4.0, 
LiDCO Ltd, Cambridge, UK) and has been widely used in clinical practice for several 
years.90 No side effects of the administration of lithium by this route have been reported. 
The device is widely available and utilises routine invasive monitoring (central venous and 
arterial catheters) to obtain cardiac output data via an external sensor. Accurate, reliable 
and repeatable cardiac output determination is essential for the successful measurement of 
EVLW volume. Lithium indicator dilution measurement of cardiac output has been 
validated in several laboratory and clinical studies.87,91,92 In anaesthetised pigs, cardiac 
output measured by lithium indicator dilution correlated more closely with measurements 
made by electromagnetic aortic flowmetry than did thermodilution.91 The first study of 
lithium indicator dilution in man was performed in nine patients immediately following 
cardiac surgery.92 Twenty two comparisons made with bolus thermodilution using the 
pulmonary artery catheter, revealed a mean bias of –0.30 l min-1 (SD 0.50). This study was 
repeated in 40 patients, most of whom had undergone cardiac surgery. A total of 200 
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comparisons were made, with a mean bias of –0.25 l min-1 (SD 0.46).87  The evidence in 
animal and human studies suggests a good correlation between lithium dilution and 
thermodilution using the pulmonary artery catheter. 
 
Using an adapted version of the LiDCO cardiac output measurement technology, where the 
mean transit time of the lithium indicator bolus is measured, it should be possible to derive 
ITBV. Simultaneous detection of a thermal signal with the subsequent incorporation of a 
thermistor would then allow calculation of EVLW. This adaptation of existing technology 
could potentially allow safe, reliable and practical measurement of EVLW volume at the 
bedside. 
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1.10 Thesis aims 
 
1. To undertake a proof of concept study to measure intrathoracic blood volume by 
lithium indicator dilution for the first time 
2. To compare the measurement of extravascular lung water using the new lithium-
thermal double indicator dilution technique to the reference standard of gravimetric 
analysis in an animal model of acute lung injury                               
3. To compare the proposed lithium-thermal double indicator dilution technique to the 
current clinically available alternatives in an animal model of acute lung injury 
4. To compare the proposed lithium-thermal double indicator dilution technique to the 
current clinically available alternatives in man 
5. To develop the lithium-thermal double indicator dilution technique into a practical 
and reliable method of EVLW measurement in clinical practice 
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Chapter 2 
Methods 
 
2.1 Double Indicator Dilution 
The only available double indicator dilution method of EVLW volume and thoracic blood 
volume measurement is the indocyanine green-thermal double indicator dilution technique 
(COLD-Z® system, Pulsion Medical Systems, Munich, Germany).  It is possible to source a 
limited number of consumables for this device but the monitor is no longer available. An 
ice cold saline indicator (0-6oC) is used for measurement of total thoracic water volume and 
indocyanine green (ICG) for measurement of intrathoracic blood volume (ITBV). ICG is a 
tricarbocyanine dye, C43H47N2NaO6S2, (figure 2.1) that is presented as a dark green powder 
in brown glass bottles to protect it from light. This powder is re-constituted with sterile 
saline before use. 
 
  
 
 
Figure 2.1 Chemical structure of indocyanine green 
 
Because ICG rapidly and completely binds to plasma proteins (95% to β-apolipoprotein) 
the molecule remains confined to the vascular compartment allowing the measurement of 
blood volumes.  ICG strongly absorbs light in the near infra-red spectrum with maximal 
N N
+
(CH2)4 (CH2)4
SO3NaSO3
_
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absorption at 805 nm.  Because there is minimal light absorption by water, oxygenated and 
de-oxygenated haemoglobin at this wavelength, generation of the characteristic dye dilution 
curve by an intravascular fibreoptic tipped catheter is possible (figure 2.2). ICG has a half-
life of 3-4 minutes in healthy volunteers and is taken up from the plasma almost exclusively 
by the hepatic parenchymal cells and is secreted entirely into the bile.93 Consequently the 
half life of ICG will be prolonged in hepatic failure. There is no effect of renal failure on 
half life. 
 
 
Figure 2.2 Near infrared absorption spectra of water, deoxygenated haemoglobin (deoxyHb), 
oxygenated haemoglobin (oxyHb) and indocyanine green (ICG) 
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In order to measure the changes in blood concentration of ICG, an 8.5 French gauge 
femoral arterial introducing sheath (Arrow; Reading, PA) is inserted by the Seldinger 
technique. A 3FG thermistor-tipped fibreoptic catheter (PV 2024; Pulsion Medical 
Systems; Munich, Germany) is then inserted into the descending aorta via the femoral 
artery sheath and connected to the COLD-Z® system (see figures 2.3 & 2.4). 
 
 
Figure 2.3 ICG-thermal catheter 
 
 
 
Figure 2.4 ICG-thermal catheter sited in right 
femoral artery 
 
Correct positioning of the catheter is essential in order to accurately identify the ICG 
concentration change. The catheter is inserted to 35cm and then slowly withdrawn until a 
strong pulsatile signal is observed on the monitor (figure 2.5).  The catheter tip must be 
positioned as close to the diaphragm as possible in order to avoid over or underestimation 
of ITBV. A pulsatile signal also indicates the catheter is positioned in an area of good blood 
flow within the aorta and is not abutting the vessel wall, which would result in signal 
 53
damping. Signal damping may affect both the ICG absorption and the thermal signals. 
Once the COLD-Z® system output is stable, the indicators can be injected (figure 2.6).  
 
 
Figure 2.5 Strong pulsatile signal indicated by 
green ‘opt signal’ and good baseline calibration 
(red 0.01). 
 
 
 
Figure 2.6 Signal stable with good catheter 
position and no baseline fluctuation (DDa & 
TDa). 
 
 
The solution for injection consists of 0.1-0.3 mg kg-1 of ICG mixed in 10-20 ml of iced 
saline. This solution is injected as a bolus into the superior vena cava via the distal port of a 
central venous catheter (figure 2.7). The COLD-Z® system is connected to the central 
venous catheter via a thermistor which detects the start of the injection, (allowing 
measurement of MTT) and measures the injectate temperature, allowing calculation of 
cardiac output (CO).  The dilution curves for ICG and ice cold saline are generated 
simultaneously in the descending aorta, from the thermistor-tipped fibreoptic catheter 
signals. CO is derived from the thermal indicator dilution curve, based on the Stewart-
Hamilton formula (equation 2.1).36,37 
 
 54
AUC
KTITBVICO .60)..( −=  
 
Equation 2.1 Calculation of cardiac output using the thermal dilution curve 
CO, cardiac output; VI, volume of injectate; TB, blood temperature; TI, injectate temperature; AUC, area under the curve; K, scaling 
factor 
 
 
 
Figure 2.7 Thermistor attached to central 
venous catheter via three-way tap and COLD-
Z machine via black data cable 
 
 
 
 
 
 
 
 
Figure 2.8 COLD-Z machine and equipment 
set-up around bed space 
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The ICG and thermal dilution curves are analysed to yield the mean transit time (MTT) of 
the indicators and the exponential downslope time (τ) (figure 1.1). CO and MTT are 
multiplied to calculate the volume between the point of injection and the point of detection. 
Multiplication of CO with the downslope time yields the volume of the largest mixing 
chamber between the point of injection and the point of detection. Mathematical analysis of 
the ICG dilution curve allows calculation of ITBV, PBV and GEDV. Mathematical 
analysis of the thermal dilution curve allows calculation of ITTV and consequent derivation 
of EVLW (figure 2.9). 
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Figure 2.9 Thoracic fluid derivation using ICG-thermal double indicator dilution 
CO, cardiac output; MTT, mean transit time; ITTV, intrathoracic thermal (water) volume; ITBV, intra-thoracic blood volume τ, 
downslope time; PBV, pulmonary blood volume; GEDV, global end-diastolic volume; ICG, indocyanine green 
 
thermalMTTCOITTV ×=
ICGMTTCOITBV ×=
ICGCOPBV τ×=
)()( ICGICG PBVITBVGEDV −=
)()( ICGthermal ITBVITTVEVLW −=
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2.2 Single Indicator Dilution 
The only commercially available device for EVLW volume and thoracic blood volume 
measurements using single indicator dilution is transpulmonary thermal indicator dilution 
(PiCCO® system, Pulsion Medical Systems, Munich, Germany).  A thermistor-tipped 
arterial catheter (5 French gauge, PV2015L20, Pulsion Medical Systems, Munich, 
Germany) is inserted into the descending aorta via the femoral artery and connected to the 
PiCCO® system.   
 
 
Figure 2.10 PiCCO catheter 
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1Ice cold saline (0-6oC) is injected as a bolus into the superior vena cava via the distal port 
of a central venous catheter, also connected to the PiCCO® system in an identical fashion to 
the COLD-Z® system (figure 2.7). In common with the COLD-Z® system the thermistor 
allows detection of the start of the injection, thus allowing the measurement of MTT, and 
also measures the injectate temperature allowing calculation of CO. The temperature 
change in the descending aorta is detected by the thermistor-tipped catheter and the 
thermodilution curve constructed. CO is calculated from the indicator dilution curve once 
again using the Stewart-Hamilton formula (see equation 2.1). 36,37 To determine ITBV, 
PBV and GEDV, the thermal dilution curve is analysed to yield the thermal indicator MTT 
and its exponential downslope time (τ) (figure 1.1). EVLW volume is then calculated 
(figure 2.11).  Measurements are taken in triplicate and averaged.  
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Figure 2.11 Calculation of extravascular lung water (EVLW) volume using the transpulmonary single 
thermal indicator dilution technique 
CO, cardiac output; MTT, mean transit time; τ, downslope time; PTV, pulmonary thermal (water) volume; GEDV, global end-diastolic 
volume; ITTV, intrathoracic thermal (water) volume; ITBV, intra-thoracic blood volume 
thermalMTTCOITTV ×=
ThermalCOPTV τ×=
PTVITTVGEDV −=
GEDVITBV ×= 25.1
ITBVITTVEVLW −=
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2.3 Lithium Indicator Dilution 
A small dose of lithium chloride (0.15-0.30mmol) is injected via a central or peripheral 
venous line, the former being preferable.94 The resulting arterial lithium concentration–time 
curve is generated by drawing blood over a single use lithium ion sensitive electrode 
attached to a peripheral arterial catheter (figure 2.12). The electrode is connected to the 
arterial catheter via a three-way tap. A small battery powered peristaltic pump is used to 
create a constant blood flow of 4.25 ml min-1 through the sensor and over the tip of the 
electrode (figure 2.13).   
 
Figure 2.12 Lithium ion sensitive electrode. Reproduced with the kind permission of Dr M. Jonas 
 
The electrode contains a reference material which provides a constant ionic environment 
and supports a membrane which is selectively permeable to lithium ions (figure 2.12). The 
potential difference across the membrane is related via the Nernst equation to the plasma 
lithium concentration. A correction for sodium concentration is therefore required because 
this is the main determinant of potential difference at baseline. A correction for packed cell 
volume is applied because lithium is distributed solely in plasma. A wick soaked in 
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heparinised saline prior to use, creates an electrical connection between blood and the 
remote reference electrode. 
 
Figure 2.13 Lithium ion sensitive electrode (bottom right) and battery operated peristaltic pump. 
 
The use of non-depolarising muscle relaxants may interfere with lithium measurements 
because the quaternary ammonium ion is also sensed by the electrode causing positive 
baseline drift. This may prevent calibration of the monitor for 15-120 minutes after drug 
administration depending on the dose and type of non-depolarising muscle relaxant. The 
more potent the drug, for example pancuronium, the less the interference because the 
equipotent dose contains fewer molecules. Because the continuous measurement of CO is 
derived by arterial waveform analysis, muscle relaxants may be used freely once calibration 
has been performed.  In common with most other methods of cardiac output measurement, 
the presence of intra cardiac shunts will also result in erroneous measurements. The 
pharmacokinetics of intra-venous lithium have been described.95 No side effects have been 
reported upon the administration of lithium by this route. The dose of lithium required for 
calibration can be used on ten successive occasions in a 40 kg anephric patient without 
exceeding the therapeutic range for oral lithium therapy. Consequently, lithium toxicity 
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does not limit use. The manufacturer does not recommend the administration of intra-
venous lithium chloride to patients who weigh less than 40kg, are pregnant or receiving 
oral lithium therapy, although the technology has been used in children. 
 
Figure 2.14 Configuration of the lithium sensor and peristaltic pump during the 
calibration process. Reproduced with the kind permission of Dr M. Jonas.  
 
2.4.1 Cardiac Output derivation 
Cardiac output is calculated from the lithium dose and the area under the concentration time 
curve prior to recirculation. 
)1(
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PCVAUC
LiClCO dose−×
×=
 
Equation 2.2 Cardiac output derivation using lithium indicator dilution 
CO, cardiac output; AUC, area under the concentration time curve; PCV, packed cell volume 
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2.4.2 Intrathoracic blood volume derivation 
Accurate ITBV measurement by lithium indicator dilution relies on accurate cardiac output 
determination and MTT measurement combined with reliable software analysis of the 
dilution curve. The timing of the lithium bolus injection is standardised by a countdown 
timer on the monitor. Intrathoracic blood volume derivation using lithium indicator dilution 
relies on identifying the indicator MTT and applying the Stewart hypothesis (Equation 1.2). 
This measurement assumes that lithium remains confined to the intravascular compartment 
during one trans-pulmonary circulation time. Although lithium ions quickly leave the intra-
vascular compartment, two studies suggest that this loss does not cause any significant 
error within the short time that elapses between injection and detection.87,89  Kurita et al 
induced acute lung injury with oleic acid in pigs having cannulated both the right and left 
ventricles. Lithium chloride was injected into the right and then left ventricle and an 
indicator dilution curve was constructed by a lithium ion sensitive electrode attached to a 
femoral arterial catheter. There was no difference in CO measured by injection into either 
ventricle.89 Band et al performed a similar study in patients with cannulae sited in both right 
and left atria during cardiac surgery. Lithium indicator dilution curves were recorded 
following injection into either the right or left atria. They concluded that loss of lithium into 
the lungs following injection into the right atrium was clinically insignificant.87 
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Figure 2.15 Calculation of ITBV using lithium indicator dilution  
ITBV, intra-thoracic blood volume;  CO, cardiac output; MTTLi, lithium indicator mean transit time;  
 
Because the lithium electrode is attached to a peripheral artery (normally the radial artery) 
and externally placed, measured MTT will include the time taken for the indicator to transit 
the arterial circulation from the margin of the thorax to the radial artery catheter, as well as 
through the external tubing to the electrode. This is represented by equation 2.3: 
 
)( electrodearmLiITBV TTMTTMTT +−=  
Equation 2.3 Derivation of physiological MTT using lithium indicator dilution 
MTTITBV, physiological MTT; MTTLi measured lithium MTT; Tarm  indicator transit time from thoracic border to radial arterial catheter; 
Telectrode time through external tubing to the electrode 
 
As the volume of the arterial catheter and extension tubing is constant and flow through this 
system is regulated by a peristaltic pump at a constant speed of 4.25 ml min-1 this 
component of measured MTT is constant. In bench studies, this value has been found to be 
13.3 seconds. The indicator transit time from the margin of the thorax to the radial arterial 
LiMTTCOITBV ×=
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catheter has been investigated, but not in the context of post operative cardiac surgical 
patients. Published data suggests transit of the indicator from the margin of the thorax to 
the wrist would be highly unlikely to result in a delay of more than 2.0 seconds. However, 
the variability of this component of the transit time has not been investigated. Consequently 
the measured MTT may vary not only due to changes in ITBV but also changes in the 
peripheral circulation. This adjustment will be discussed further in the subsequent chapters. 
)sec3.13( ++= armITBVLi TMTTMTT  
Equation 2.4 Derivation of measured Lithium MTT  
MTTLi, measured lithium MTT; MTTITBV, physiological MTT; Tarm  indicator transit time from thoracic border to radial arterial catheter  
 
2.4 Gravimetry 
The laboratory study involves a modified post-mortem gravimetric method to calculate 
extra-vascular lung water volume.34,61,96 Immediately prior to animal sacrifice, 60 ml of 
central venous blood is taken for determination of the haemoglobin concentration, 
haematocrit and wet:dry mass ratio of blood. The lungs are removed immediately post 
mortem, drained of blood, and weighed. An amount of water equal to the weight of the 
lungs is added to induce haemolysis. The lungs and the added water are then homogenized 
using a commercial blender and a homogenizer. Half of the homogenate is used to 
determine its wet:dry mass ratio and the other half centrifuged at 30,000g for one hour at 
4°C to obtain a supernatant. The supernatant is separated and the haemoglobin 
concentration and wet:dry mass ratio determined. The dry weights of the blood, 
homogenate and supernatant are determined after three days incubation in a heat chamber 
at 85°C. EVLW is then calculated according to the formula described in figure 2.16. 
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Figure 2.16 Formulae used in gravimetric determination of EVLW  
Qlb = weight of removed lungs; Qwt = weight of added water; Wwb = wet weight of blood; Wdb = dry weight of blood; Fwb = fraction 
water of blood; Wwh = wet weight homogenate; Wdh = dry weight homogenate; Fwh = fraction water of homogenate; Wws = wet 
weight supernatant; Wds = dry weight supernatant; Fws = fraction water supernatant; Hct = haematocrit; Qb = residual blood content in 
lungs; Qr = Red cell mass of lung; Qh = total weight of homogenate; Hbs = haemoglobin concentration in supernatant; Hbb = 
haemoglobin concentration in blood; EVLW = extravascular lung water 
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Chapter 3  
Measurement of intrathoracic blood volume using trans-
pulmonary lithium indicator dilution: a proof of concept 
study 
 
3.1 Introduction 
Increased extravascular lung water (EVLW) volume during critical illness is associated 
with prolonged mechanical ventilation, delayed recovery and increased mortality rates.25,28-
30 Quantification of EVLW volume allows treatment to be adjusted to regulate lung water, 
perhaps resulting in improved clinical outcomes.29,30 Neither assessment of oxygenation nor 
chest radiography provide a reliable indication of EVLW volume, 17,18,20 and there is as yet 
no ideal method for measuring EVLW volume at the bedside. 
 
The clinical reference standard for EVLW volume measurement is the trans-pulmonary 
indocyanine green-thermal double indicator dilution technique, the theoretical and 
methodological descriptions of which are described in sections 1.4.2 and 2.1.  At present, 
the only commercially available method of EVLW volume measurement is the trans-
pulmonary (single) thermal indicator dilution technique as described in section 1.4.3, 
however, there is some concern regarding the validity of this approach.66  
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One solution might be to measure ITBV by the trans-pulmonary lithium indicator dilution 
technique. In combination with thermodilution, EVLW volume could be calculated without 
relying on the mathematical assumptions made when using thermodilution alone. Lithium 
chloride satisfies many of the criteria for an ideal indicator and ITBV measurements could 
be made using an adapted version of cardiac output measurement technology which has 
been in clinical use for several years.87-89,91,92 The small displacement volume of the lithium 
indicator minimises measurement error and, in contrast to trans-pulmonary thermal (single) 
indicator dilution,97-100 there does not appear to be any significant loss of lithium indicator 
between injection and sampling sites.87,89 The technique is straightforward and less 
expensive than indocyanine green indicator dilution and in combination with 
thermodilution would allow EVLW volume measurement by double indicator dilution 
using existing technology.  
 
However, the measurement of ITBV by lithium indicator dilution has not previously been 
described and might be affected by a number of potential sources of error. The aims of this 
study were to measure ITBV using lithium indicator dilution for the first time, allowing 
validation of this concept and comparison with published data collected using indocyanine 
green indicator dilution. 
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3.2 Methods 
3.2.1 Patients 
This single centre, observational study was prospectively approved by the Local Research 
Ethics Committee. Patients aged over 50 years undergoing elective cardiac surgery with 
cardio-pulmonary bypass were eligible for recruitment according to pre-defined criteria. 
The peri-operative changes in ITBV and EVLW volume in this population are significant 
and well described.101-104 Patients were screened for eligibility prior to surgery and written 
informed consent obtained.  Exclusion criteria were refusal of consent, concurrent lithium 
therapy, pregnancy and weight less than 40 kg. Patients with acute arrhythmias, severe 
peripheral vascular disease, significant cardiac valvular regurgitation and intra-aortic 
balloon counterpulsation were also excluded as these conditions could affect forward flow 
of the lithium indicator. 
 
3.2.2 Clinical Management 
A 20G right radial arterial catheter was inserted prior to induction of general anaesthesia 
with propofol 2-3 mg kg-1, fentanyl 3-5 µg kg-1 and vecuronium 0.1 mg kg-1. Anaesthesia 
was maintained with inhaled isoflurane and boluses of fentanyl and vecuronium as 
required. A right internal jugular central venous catheter was then inserted prior to surgery. 
Cardio-pulmonary bypass was managed by a perfusionist in consultation with anaesthetic 
and surgical staff. The bypass circuit was primed with two litres of Ringer’s lactate solution 
and 15,000 international units of heparin. Packed red blood cells were administered to 
maintain a haemoglobin concentration above 8 g dl-1. Cumulative fluid balance data was 
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obtained from anaesthetic and perfusionist records in theatre and nursing charts in the 
critical care unit. Invasive ventilation was standardised according to best practice.105 Initial 
settings were as follows: mandatory rate of 12 breaths per minute, positive end-expiratory 
pressure of 5 cm H2O and tidal volume 7 ml kg-1. Patients were managed in a critical care 
unit following surgery, where sedation was discontinued and the tracheal tube removed by 
clinical staff according to local protocols. 
 
3.2.3 ITBV measurements 
Measurements were performed following induction of anaesthesia, after discontinuation of 
cardio-pulmonary bypass and sternotomy closure, and then two, four and 24 hours 
following surgery using the method described in chapter 2. Measurements were made a 
minimum of 25 minutes following the administration of non-depolarising muscle relaxants 
in order to avoid any baseline drift of the lithium sensor voltage. A lithium concentration–
time curve was constructed and values of cardiac output and ITBV were calculated 
automatically, allowing for the proposed indicator transit time down the arm and through 
the external equipment (see section 2.4.2). The time of injection was standardised through 
the use of a visual countdown on the monitor (LiDCOplus™ version 4.0, LiDCO Ltd, 
Cambridge, UK).  
 
3.2.4 Statistical analysis 
Data from previous work suggested that ITBV may typically rise by 7.5ml kg-1 during 
cardio-pulmonary bypass and that values change by between 5% and 10% during the first 
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24 hours after surgery.103,104 Assuming a type I error rate of 5% and a type II error rate of 
10%, it was estimated that 20 patients would be required to detect a change in ITBV of 1.5 
ml kg-1 (standard deviation (SD) 2 ml kg-1). Data are presented as mean (SD) where 
normally distributed, and median (inter-quartile range [IQR]) where not normally 
distributed. The significance of peri-operative changes in ITBV was tested using repeated 
measures analysis of variance (ANOVA) with Tukey’s correction. The association between 
cardiac index and ITBV was tested using linear regression. Analysis was performed using 
GraphPad Prism version 4.0 (GraphPad Software, San Diego, USA). Significance was set 
at p<0.05. 
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3.3 Results 
Twenty patients were recruited in July and August 2006. The baseline characteristics of 
these patients are presented in table 3.1 and physiological data in table 3.2. In four patients, 
the arterial catheter occluded and was removed before the final 24 hour measurement could 
be taken. No difficulties were encountered due to baseline sensor drift caused by prior use 
of non-depolarising muscle relaxants.  
 
ITBV data is presented in table 3.3 and figure 3.1. Initial ITBV values were slightly less 
than the quoted normal range 106 but changed significantly during the peri-operative period 
(p<0.0001). Values peaked at two hours following surgery before returning to normal for 
many patients by the first post-operative day. Linear regression analysis indicated a weak 
relationship between ITBV and cardiac index (r2=0.22, p<0.0001) (figure 3.2). There was 
also a weak relationship between ITBV and MTT (r2=0.29, p<0.0001) (Figure 3.3). 
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n 20 
Age 70 years [64-75] 
Gender 13 male, 7 female 
Weight 76 kg [67 – 86] 
Parsonnet score 10 [1 – 13.5] 
Duration of cardio-pulmonary bypass 99 minutes [60 – 130] 
Coronary artery bypass graft 15 
Aortic valve replacement 2 
Coronary artery bypass graft and aortic 
valve replacement as combined 
procedure 
3 
 
 
 
 
Table 3.1 Baseline patient characteristics 
Data presented as median [SD] 
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Time Pre-bypass Post-bypass 2 hours 4 hours 24 hours 
MAP (mm Hg) 70.5 [64-75] 63.0 [58-69] 66.5 [63-76] 69.5 [63-76] 72.0 [68-78] 
CVP (mm Hg) 8 [7-9] 9 [6-11] 11 [10-14] 12 [10-13] 14 [8-16] 
CI (l min-1 m-2) 1.98 (±0.45) 1.92 (±0.42) 2.22 (±0.56) 2.29 (±0.58) 2.56 (±0.94) 
PaO2 (kPa) 33.2 (±13.3) 30 (±12.0) 18.0 (±4.2) 15.9 (±3.2) 12.1 (±3.1) 
PaO2:FiO2 (kPa) 58 (±20) 38 (±18) 42 (±10) 43 (±11) n/a 
VT (ml) 529 (±77) 535 (±77) 536 (±73) 525 (±110) n/a 
PEEP 
(cm H2O) 
5 [5-5] 5 [5-5] 5 [5-5] 5 [5-5] n/a 
Peak PAW 
(cm H2O) 
19 [17-25] 21 [19-23] 24 [19-28] 20 [15-26] n/a 
Cumulative 
fluid balance 
(ml) 
0 3145 (±1141) 3325 (±1173) 3955 (±1113) 5821 (±1683) 
 
 
Table 3.2 Physiological parameters.  
Data presented as mean (SD) or median [IQR]. MAP, mean arterial pressure; CVP, central venous pressure; CI, cardiac index; VT, tidal 
volume; PEEP, positive end-expiratory pressure; Peak PAW, peak airways pressure.  
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Time Pre-bypass Post-CPB 2 hours 4 hours 24 hours p 
ITBV  
(ml) 
1542  
(±601) 
1942  
(±562) 
2318*  
(±524) 
2268*  
(±889) 
1873 
(±658) <0.001 
ITBV  
(ml m-2) 
849  
(±336) 
1068  
(±287) 
1265*  
(±273) 
1244*  
(±431) 
1100  
(±357) <0.001 
ITBV  
(ml kg-1) 
20.9  
(±9.6) 
26.0  
(±7.5) 
31.0* 
(±7.4) 
30.0*  
(±11.2) 
20.0  
(±12.9) <0.001 
CI  
(l min-1 m-2) 
1.98  
(±0.45) 
1.92  
(±0.42) 
2.22  
(±0.56) 
2.29  
(0.58) 
2.56*  
(±0.94) <0.05 
MTT  
(seconds) 25.5 (±6.3) 34.0 (±9.4)* 36.2 (±10.6)* 33.7 (±12.2)* 25.6 (±7.1) <0.0001 
 
Table 3.3 Lithium indicator dilution data  
Data presented as mean (SD) or median [IQR]. ITBV, Intrathoracic blood volume; CI, cardiac index; MTT, mean transit time. * indicates 
significant changes with respect to pre-op values. ITBV is presented in three different formats (ml, ml m-2 and ml kg-1) to allow 
comparison with previous work. 
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Figure 3.1 Intrathoracic blood volume (ITBV) as measured by lithium indicator 
dilution at different time-points 
Data presented as mean (SD). Changes in ITBV highly significant (p<0.0001, repeated measures ANOVA).  
* indicates significant changes with respect to pre-op values. Shaded area indicates normal value of ITBV. 
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Figure 3.2 Linear regression analysis of the relationship between cardiac index (CI) 
and intrathoracic blood volume (ITBV). r2=0.22.  
Dotted lines signify 95% confidence intervals for gradient. Discussed in section 3.4.3. 
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Figure 3.3 Linear regression analysis of the relationship between mean transit time 
(MTT) and intra-thoracic blood volume (ITBV). r2=0.29  
Dotted lines signify 95% confidence intervals for gradient. Discussed in section 3.4.3. 
 79
3.4 Discussion 
3.4.1 Summary of findings 
This proof of concept study of the use of lithium indicator dilution to measure ITBV 
identified significant peri-operative changes in ITBV which were consistent with 
previously published data.104 These findings suggested that ITBV measurement by lithium 
indicator dilution using an external electrode is valid and that further work to develop a 
trans-pulmonary double indicator dilution technique utilising lithium and thermal indicators 
to measure EVLW volume would be worthwhile. 
 
3.4.2 Comparison to previous work 
The measurements of ITBV in this study were consistent with those taken during previous 
investigations.104,106-108 Direct comparison between studies is not straightforward because 
previous reports present data indexed either according to body mass, surface area or as 
absolute values (see table 3.3). Both peri-operative trends and absolute measurements of 
ITBV in this study were consistent with those taken using indocyanine green indicator 
dilution during and after cardiac surgery with cardio-pulmonary bypass.104 The median 
absolute value of ITBV measured at baseline using indocyanine green was 1417 (±208) ml 
which was similar to the baseline measurement of 1542 (±601) ml obtained using lithium 
indicator dilution. Measurements of ITBV using lithium indicator dilution were also 
comparable to indocyanine green dilution measurements in healthy volunteers (741 [±54] 
ml m-2), ventilated patients without pulmonary oedema (1410 [±294] ml) and patients 
admitted to intensive care with acute respiratory failure (881 [±64] ml m-2). 106-108 
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3.4.3 Potential sources of error 
Most recent studies of indocyanine green indicator dilution have utilised a 
spectrophotometric catheter inserted via the femoral artery so that the tip lies within the 
aorta close to the diaphragm and therefore at the margin of the thoracic cavity. Whilst this 
approach allows a direct measurement of mean indicator transit time, it is also more 
invasive, requiring placement of a specialised arterial catheter. In contrast, the lithium ion 
sensitive electrode utilised in this study was designed for external use. Whilst less invasive, 
the concern was that this approach may introduce measurement error due to the difference 
between the measured and trans-thoracic values of mean transit time. It is reassuring 
therefore, that whilst linear regression analysis identified highly significant relationships 
between ITBV and both cardiac output and mean transit time, neither relationship was 
sufficient in isolation to explain the observed changes in ITBV. This is important as 
changes in ITBV should be independent of changes in CO and MTT and not 
mathematically coupled. This would suggest that the assumption of a fixed time delay due 
to indicator transit from the margin of the thoracic cavity to the external electrode does not 
prevent a valid calculation of ITBV by this method.  
 
3.4.4 Benefits of this technique 
This technique was very straightforward and easy to use at the bedside. The additional cost 
of the consumables and lithium indicator is minimal and calibration does not inhibit 
ongoing clinical care. One major concern prior to this study was the potential interference 
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of non-depolarising muscle relaxants (NDMR) causing positive drift of the LiDCO 
baseline. This phenomenon was not observed during the duration of the study, probably 
because a potent NDMR was used for induction and maintenance of anaesthesia and the 
time taken to site invasive monitoring post induction and pre-bypass was sufficient to allow 
plasma levels of the NDMR to fall. 
 
3.4.5 Conclusions 
This initial proof of concept study confirmed the feasibility of measuring ITBV by lithium 
indicator dilution. In combination with thermodilution, this method could potentially 
provide a practical but accurate double indicator dilution method of extravascular lung 
water volume measurement at the bedside. Further clinical and laboratory studies are 
required to evaluate the accuracy of ITBV and EVLW volume measurement using this 
technique.  
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Chapter 4 
Estimation of extra-vascular lung water volume 
measurement by lithium-thermal indicator dilution in 
porcine models of acute lung injury: Comparison of three 
techniques to post-mortem gravimetry  
4.1 Introduction 
 
The laboratory reference technique of EVLW volume measurement is post-mortem 
gravimetry. EVLW volume is calculated from a number of measurements allowing 
estimation of the wet:dry weight ratio of the lung and hence derivation of EVLW volume as 
described in section 2.4.34  The accepted clinical reference technique for measuring EVLW 
volume (ICG-thermal double indicator dilution) was validated in several animal models by 
comparison with gravimetry.34,45,46 The only device currently commercially available for 
EVLW volume measurement (single thermal indicator dilution) was also validated in 
studies using comparison with gravimetry.61,63,64 However there appeared to be a trend to 
over-estimation at higher EVLW volumes perhaps due to the mathematical assumptions 
made in the derivation of ITBV. These assumptions may be invalid in some common 
clinical situations.60-62 
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The initial proof of concept study confirmed the feasibility of ITBV measurement by 
lithium indicator dilution in cardiac surgical patients. By combining the trans-pulmonary 
lithium indicator dilution measurement of ITBV with a thermodilution measurement of 
ITTV, derivation of EVLW volume should be possible.  There is a need to confirm the 
accuracy of this proposed method and to compare this to the alternative technologies. 
 
The aims of this study were to compare gravimetric EVLW volume measurements with 
those made by the lithium-thermal double indicator dilution, ICG-thermal double indicator 
dilution and single-thermal indicator techniques in porcine models of acute lung injury. 
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4.2 Methods  
This study was performed using two porcine models designed to invoke systemic 
inflammatory and associated cardiovascular and respiratory responses. These were a caecal 
ligation and puncture model of faecal peritonitis induced septic shock and an aortic balloon 
occlusion model of visceral ischaemia. In line with the principles of reduction and 
refinement, this investigation was conducted as part of two ongoing interventional 
laboratory studies to minimise unnecessary animal use. The protocols of these studies were 
approved by the Animal Care Committee of the University of Ulm, Germany as well as the 
governmental animal protection authorities (Regierungspräsidium Tübingen, Germany).  
All animals were fasted for 18 hours prior to each experiment with unrestricted access to 
water. They were premedicated, an auricular vein cannulated and anaesthetised, the details 
of which are given in sections 4.2.1 and 4.2.2. After orotracheal intubation, ventilator 
parameters were identical in both studies and set according to clinical standards: volume-
controlled ventilation, tidal volume (VT) 8 ml kg-1, PAW < 40 cmH2O, Positive End 
Expiratory Pressure (PEEP) 10 cmH2O, I:E ratio 1:1.5, respiratory rate titrated to maintain 
PaCO2 at 35-45 mmHg. If the PaO2:FiO2 ratio decreased below 300 mmHg, the I:E ratio 
was increased to 1:1 and PEEP was increased to 12 cmH2O. If the PaO2:FiO2 ratio 
decreased below 200 mmHg, PEEP was increased to 15 cmH2O. FiO2 was set at the 
minimum level needed to maintain arterial haemoglobin saturation (SaO2) above 90%. 
4.2.1 Faecal peritonitis-induced sepsis model 
Anaesthesia was induced with propofol (1-2 mg kg-1) and ketamine (1-2 mg kg-1) and 
maintained by pentobarbital infusion (0.14 mg kg-1 hr-1) with intermittent boluses of 
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buprenorphine (30 µg kg-1). Muscle relaxation was achieved by a continuous intravenous 
alloferin infusion (0.28 mg kg-1 hr-1). Intra-venous 6% hydroxyethylstarch was infused at 
15 ml kg-1 hr-1 or at 10 ml kg-1 hr-1 if the pulmonary artery occlusion pressure was greater 
than 18 mmHg. A noradrenaline infusion was commenced when mean arterial pressure 
could no longer be maintained within 20% of baseline by volume resuscitation alone. 8.5 
FG introducer sheaths were introduced into the right and left femoral arteries.  A thermistor 
tipped catheter for single-thermal indicator dilution measurements (single-thermal, see 
section 4.2.5) was placed into the right femoral artery which also allowed continuous 
pressure monitoring, blood sampling and lithium indicator dilution measurements. A 
thermistor tipped fibreoptic catheter for indocyanine green-thermal double indicator 
dilution (ICG-thermal) measurements was placed into the left femoral artery (see section 
4.2.4). Introducer sheaths were placed in the left and right jugular veins. A pulmonary 
artery catheter was introduced into the right jugular vein and a central venous catheter into 
the left. A midline laparotomy and ileostomy was performed and a number of measurement 
probes placed for the purposes of the interventional study. Puncture epicystostomy was 
performed to monitor urine output. After a delay of six hours to allow animal recovery, 
initial indicator dilution measurements were performed. Faecal peritonitis and septic shock 
was then induced by the introduction of autologous faeces (0.5 g kg-1) into the abdominal 
cavity through indwelling abdominal tubes.109 Once noradrenaline was commenced the 
experimental animals were randomized into one of various groups for the interventional 
study. The observation period continued for another 24 hours in each group during which 
three further indicator dilution measurements were made at twelve, eighteen and twenty 
four hours. The experimental animals were then sacrificed by injection of intravenous 
potassium chloride under deep pentobarbital anaesthesia. 
 86
4.2.2 Aortic balloon occlusion-induced ischaemia-reperfusion model 
Anaesthesia was induced with propofol (3-5 mg kg-1) and ketamine (1-2 mg kg-1) and 
maintained with propofol (6-8 mg kg-1 hr-1) and remifentanil infusions (15-20 µg kg-1 hr-
1).110 Ringers lactate solution was infused at 10 ml kg-1 hr-1 for the duration of the study. 
Intra-venous hydroxyethylstarch was given at the anaesthetist’s discretion intra-operatively 
and infused at 250 ml hr-1 starting two hours prior to aortic occlusion until the end of the 
study at eight hours of reperfusion. Introducer sheaths were placed in the right and left 
femoral arteries for placement of balloon catheters to facilitate aortic occlusion at the level 
of the left subclavian artery and the aortic bifurcation. The right and left internal jugular 
veins were exposed for the introduction of pulmonary artery and central venous catheters 
respectively. The right carotid artery was exposed for placement of two introducer sheaths 
for the ICG-thermal and single-thermal catheters as well as arterial pressure monitoring.  
The lithium sensitive electrode was attached to the single-thermal catheter as per the caecal 
ligation induced sepsis model.  Puncture epicystostomy was performed to monitor urine 
output. For the purposes of the interventional experiment, a delay of two hours after closure 
of all incisions allowed the animal to be prepared for either placebo or target drug 
infusions. Following this two hour delay, the aorta was occluded for 30 minutes, with the 
mean arterial pressure controlled to within 20% of the baseline using continuous glyceryl 
trinitrate, esmolol and adenosine triphosphate infusions. Noradrenaline was used to 
maintain mean arterial pressure during the early reperfusion period. After 8 hours the 
animals were sacrificed by injection of intravenous potassium chloride under deep 
pentobarbital anaesthesia. 
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4.2.3 ITBV measurement using lithium indicator dilution 
ITBV was measured using lithium indicator dilution as described in section 2.3. However 
in the aortic balloon occlusion-induced ischaemia/reperfusion model, the external sensor 
was attached to the carotid arterial catheter because both femoral artery catheters were 
required for introducing the balloon catheters. The flow of arterial blood across the lithium 
sensor was regulated using a battery powered peristaltic pump. The time of injection was 
standardised through the use of visual instructions on the monitor. There were problems 
initially acquiring the indicator dilution curve with a standard five second countdown and 
software analysis. Initial attempts resulted in appearance of the lithium indicator dilution 
curve before activation of the software. Consequently in these experiments a further 10 
second delay was implemented to allow data capture by the device. 
 
4.2.4 ITBV & EVLW  measurement using the COLD-Z method 
ITBV, ITTV and EVLW volume measurements were made using the ICG-thermal indicator 
dilution technique. (COLD-Z, Pulsion Medical Systems, Munich) detailed in chapter 2, 
section 2.1.111 10ml of iced 5% dextrose solution containing 25mg ICG was injected via the 
central venous catheter. Changes in temperature and ICG concentration were detected using 
a thermistor tipped fibreoptic arterial catheter (Pulsiocath PV 2024 4F, Pulsion Medical 
Systems) attached to the COLD-Z monitor. 
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4.2.5 ITBV & EVLW  measurement using the PiCCO method 
ITBV, ITTV and EVLW volume measurements were made using single-thermal indicator 
dilution. (PiCCO, Pulsion Medical Systems, Munich) detailed in section 2.2. 10ml of iced 
normal saline was injected via the central venous catheter.112 Changes in arterial blood 
temperature were detected by a thermistor tipped arterial catheter attached to the PiCCO 
monitor. 
 
4.2.6 EVLW measurement using lithium-thermal double indicator dilution 
EVLW volume measurement is not possible using the lithium indicator dilution technology 
as currently designed since only ITBV can be measured. Consequently another method 
must be used to measure ITTV. The calculation of EVLW volume relies on subtraction of 
ITBV from ITTV, but this simple mathematical principle can not be applied when these 
volumes are each measured by different devices. This is due to the variability in cardiac 
output measurement, however small, which is commonly observed between different 
techniques. In order to estimate EVLW using the lithium-thermal technique an alternative 
strategy using MTT must be adopted.  
 
LiCOxMTTITBV =  
Equation 4.1 Derivation of ITBV using lithium indicator dilution 
ITBV, intrathoracic blood volume; CO, cardiac output; MTTLi lithium indicator mean transit time 
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thermalCOxMTTITTV =  
Equation 4.2 Derivation of ITTV using thermal indicator dilution 
ITTV, intrathoracic thermal volume; CO, cardiac output; MTThermali single-thermal indicator mean transit time 
 
Consequently as EVLW=ITTV-ITBV, this equation can be re-written as: 
)()( Lithermal COxMTTCOxMTTEVLW −=  
or 
)( LithermalLi MTTMTTxCOEVLW −=  
Equation 4.3 Derivation of EVLW using lithium-thermal double indicator dilution 
EVLW, Extravascular lung water volume; ITTV, intrathoracic thermal volume; COLi, cardiac output measured by lithium indicator 
dilution; MTThermali single-thermal indicator mean transit time; MTTLi lithium indicator mean transit time 
 
To negate the variability of cardiac output measurement, the re-written EVLW equation 
demonstrates that EVLW was calculated by subtracting the MTT of the lithium indicator 
from the MTT of the COLD-Z thermal indicator which was then multiplied by the cardiac 
output derived from lithium indicator dilution (see equation 4.3). 
 
4.2.7 Cardiac output measurement 
Cardiac output measurement is fundamental to the calculation of EVLW and can be 
measured using a number of techniques. It is unlikely that the measurements obtained using 
these different technologies will be identical, and that any variability could be reflected in 
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the calculation and subsequent comparison of thoracic fluid volumes.  The accepted clinical 
reference standard of cardiac output measurement is thermodilution using a pulmonary 
artery catheter (PAC). In order to allow sensible comparison between each technique, 
immediately prior to each measurement point, cardiac output was measured using the PAC 
with three measurements taken at the end of expiration and averaged using a cardiac output 
computer (Sat-2; Baxter Edwards Lifesciences, Irvine, USA). 
 
4.2.8 Post-mortem EVLW volume measurement: 
Extra-vascular lung water volume was determined using the modified gravimetric method 
described in section 2.4.   
 
4.2.9 Measurement time points 
During the sepsis model, measurements were performed immediately prior to the 
introduction of autologous faeces into the abdominal cavity, then at 12, 18 and immediately 
prior to animal sacrifice at 24 hours. Lithium indicator dilution measurements were made a 
minimum of 25 minutes after discontinuation of the alloferin infusion to avoid any baseline 
drift of the lithium sensor voltage. During the aortic cross clamp model, measurements 
were made immediately prior to clamping, then at 1 and 4hrs, and then immediately prior to 
animal sacrifice at 8 hours after clamp release, giving a total of 4 comparisons with each 
technique in each model.  
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4.2.10 Statistical analysis  
Assuming a type I error rate of 5% and a type II error rate of 10%, it was estimated that 48 
comparisons in 12 animals would be required to detect a 1.0 ml kg-1 difference in EVLW 
volume between the lithium-thermal and indocyanine green-thermal double indicator 
dilution techniques, assuming a standard deviation of the difference between paired 
readings of 2 ml kg-1. 
 
ITBV and EVLW volume measurements were compared using the technique of Bland and 
Altman with comparisons presented as bias (±95% limits of agreement [LOA]). Percentage 
error was calculated according to the method reported by Critchley as the limit of 
agreement (±2 SD) of the bias divided by the mean CO from the two methods under 
comparison.113 Data are presented as mean (SD) where normally distributed, and median 
(inter-quartile range [IQR]) where not normally distributed.  Parametric data were 
compared using the unpaired t-test and non-parametric data were compared with the Mann-
Whitney test. Differences in measurements of EVLW volume, ITBV and CO over time, 
made using the three study techniques, were compared using repeated measures analysis of 
variance (ANOVA) with Tukey’s correction. Significance was set at p<0.05. 
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4.3 Results 
Twelve animals were included in the interventional experiments during the study period. 
Comparative data was obtained for all measurement techniques in ten animals, with loss of 
LiDCO data in one animal due to a damaged cable and another due to loss of lung tissue 
with the gravimetric technique.  Physiological data is shown in table 4.1 illustrating 
changes in respiratory parameters throughout the study consistent with ALI (n=10) with 
tables 4.2 and 4.3 showing this data in each model.  Data illustrating thoracic fluid volumes 
throughout the study is shown in table 4.4 and for each model is shown in tables 4.5 and 
4.6. 
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Timepoint Baseline 2 
 
3 
 
Final p 
Heart Rate (bpm) 70 (± 18) 114 (± 36) 97 (± 46) 95 (± 51) 0.12 
Mean Arterial 
Pressure (mmHg) 94 (± 11) 91 (± 11) 87 (± 14) 76 (± 17)* <0.05 
PAC Cardiac 
Output 
(l min-1) 
4.3 (± 1.1) 5.4 (± 2.1) 4.4(± 1.4)  4.0 (± 1.2) 0.18 
pH 7.55 (± 0.04) 7.45 (± 0.07) 7.48 (± 0.05) 7.46 (± 0.07)* <0.01 
PaO2 (mmHg) 
163  
(± 12) 
124*  
(± 21) 
117*  
(± 22) 
102*  
(± 33) <0.0001
PaO2:FiO2 
(mmHg) 465 (± 35) 354 (± 60)* 335 (± 64)* 263 (± 129)* <0.0001
Positive End 
Expiratory 
Pressure  
(cm H2O) 
10 [10-10] 10 [10-10] 10 [10-10] 10 [10-12] 0.55 
Peak PAW  
(cm H2O) 
20 (± 2) 23 (± 4) 25 (± 5) 28 (± 7)* <0.05 
Cumulative fluid 
balance (litres) 3.4 (± 2) 7.4(± 5.7) 9.4 (± 7.7) 13.5 (± 6.5)* <0.01 
 
Table 4.1 Physiological data in both models combined 
Data presented as mean (SD) or median [IQR]. PAC, pulmonary artery catheter. * indicates significant changes with respect to baseline 
values.
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Timepoint Baseline 
 
12 hours 
 
 
18 hours 
 
24 hours p 
Heart Rate 
(bpm) 78 (± 17)  126 (± 32)  125 (± 36) 127 (± 40)*   <0.05  
Mean Arterial 
Pressure 
(mmHg) 
 97 (± 10) 94 (± 13) 87 (± 18) 71 (± 20)*  <0.05 
PAC Cardiac 
Output 
(l min-1) 
 4.8 (± 1.1) 4.4 (± 0.8) 4.6 (± 1.4) 4.5 (± 1.4)  0.94 
pH 7.54 (± 0.03) 7.50 (± 0.03) 7.48 (± 0.05) 7.44 (± 0.06)*  <0.002 
PaO2 (mmHg) 
167 
(± 15) 
125*  
(± 27) 
108*  
(± 14) 
92**  
(± 16) <0.0001 
PaO2:FiO2 
(mmHg) 477 (± 42) 358 (± 78)* 310 (± 39)* 234 (± 79)** <0.0001 
Positive End 
Expiratory 
Pressure  
(cm H2O) 
10 [10-10] 10 [10-10] 10 [10-10] 12 [10-12] 0.55 
Peak PAW  
(cm H2O) 
21 (± 2) 19 (± 1) 27 (± 4) 31 (± 7)* <0.01 
Cumulative 
fluid balance 
(litres) 
4.8 (± 0.9) 11.5 (± 3.0)* 14.8 (± 4.3)* 17.8 (± 4.6)* <0.0001 
 
 
Table 4.2 Physiological variables for the sepsis model (n=6) 
Data presented as mean (SD) or median [IQR]. PAC, pulmonary artery catheter. * indicates significant changes with respect to baseline 
values. ** indicates significant changes with respect to baseline and 12 hour values.
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Timepoint Baseline 
 
1 hour 
 
 
4 hours 
 
 
8 hours 
 
p 
Heart Rate 
(bpm)  59 (± 17) 95 (± 38) 55 (± 18) 47 (± 7)** <0.05   
Mean Arterial 
Pressure 
(mmHg) 
 89 (± 12) 86 (± 8) 88 (± 7) 84 (± 9) 0.87  
PAC Cardiac 
Output 
(l min-1) 
 3.7 (± 1.1) 5.5 (± 1.1) 5.1 (± 3.8) 3.9 (± 1.5) 0.61  
pH 7.55 (± 0.05) 7.38 (± 0.06)* 7.48 (± 0.08) 7.49 (± 0.08) <0.05  
PaO2 (mmHg) 
157  
(± 2) 
122  
(± 7) 
131  
(± 28) 
119  
(± 48)  0.26 
PaO2:FiO2 
(mmHg) 448 (± 7) 347 (± 22) 374 (± 80) 305 (± 187) 0.3  
Positive End 
Expiratory 
Pressure  
(cm H2O) 
10 [10-10] 10 [10-10] 10 [10-10] 10 [10-10] 0.55  
Peak PAW  
(cm H2O) 
19 (± 2) 19 (± 1) 20 (± 1) 22(± 4) 0.1  
Cumulative 
fluid balance 
(litres) 
1.2 (± 0.2) 1.2 (± 0.2) 1.2 (± 0.2) 7.2 (± 1.2)* <0.0001 
 
 
Table 4.3 Physiological variables for the aortic balloon occlusion model (n=4) 
Data presented as mean (SD) or median [IQR]. PAC, pulmonary artery catheter. * indicates significant changes with respect to baseline 
values. ** indicates significant changes with respect to 1 hour values.
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Timepoint Baseline 
 
2 
 
 
3 
 
 
Final 
 
Li-thermal ITBV 
(ml kg-1) 21.8 (± 3.7) 22.2 (± 7.8) 20.6 (± 6.0) 22.4 (± 6.3) 
ICG-thermal 
ITBV 
(ml kg-1) 
30.7 (± 8.1) 28.7 (± 3.7) 28.1 (± 3.7) 27.0 (± 4.3) 
Single-thermal 
ITBV 
(ml kg-1) 
27.1 (± 7.4) 23.0 (± 5.0) 22.4 (± 5.9) 26.4 (± 5.3) 
Gravimetric 
EVLW volume  
(ml kg-1) 
- - - 9.2 (± 3.0) 
Li-thermal EVLW 
volume 
(ml kg-1) 
5.9 (± 5.1) 7.4 (± 9.0) 6.6 (± 6.2) 7.5 (± 6.5) 
ICG-thermal 
EVLW volume 
(ml kg-1) 
4.7 (± 2.3) 6.7 (± 3.4) 5.5 (± 3.3) 7.7 (± 3.7) 
Single thermal 
EVLW volume 
(ml kg-1) 
13.3 (± 6.3) 12.3 (± 2.1) 11.5 (± 2.5) 15.5 (± 4.7) 
 
Table 4.4 Thoracic fluid volumes (n=10) 
Data presented as mean (SD).  Li-thermal, lithium-thermal double indicator dilution; ICG-thermal, indocyanine green-thermal double 
indicator dilution; single-thermal,  single-thermal indicator dilution; ITBV, intrathoracic blood volume; EVLW, extravascular lung water 
volume. 
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Timepoint Baseline 
 
12 hours 
 
 
18 hours 
 
24 hours 
Li-thermal ITBV 
(ml kg-1) 20.0 (± 3.7) 17.7 (± 3.5) 17.0 (± 4.4) 19.8 (± 5.5) 
ICG-thermal 
ITBV 
(ml kg-1) 
32.8 (± 8.4) 30.8 (± 8.6) 28.8 (± 4.4) 28.2 (± 4.1) 
Single-thermal 
ITBV 
(ml kg-1) 
28.5 (± 8.4) 20.3 (± 2.7) 20.8 (± 3.2) 24.6 (± 4.8) 
Gravimetric 
EVLW volume  
(ml kg-1) 
 -  -  -  9.8 (± 3.6) 
Li-thermal EVLW 
volume 
(ml kg-1) 
8.8 (± 4.0) 12.0 (± 8.4) 8.5 (± 6.3) 9.1 (± 6.7) 
ICG-thermal 
EVLW volume 
(ml kg-1) 
4.9 (± 2.7) 6.7 (± 3.1) 5.6 (± 3.5) 7.9 (± 4.3) 
Single thermal 
EVLW volume 
(ml kg-1) 
14.0 (± 8.3) 11.3 (± 1.8) 10.0 (± 1.3) 13.5 (± 3.3) 
 
Table 4.5 Thoracic fluid volumes for the sepsis model (n=6)  
Data presented as mean (SD).  Li-thermal, lithium-thermal double indicator dilution; ICG-thermal, indocyanine green-thermal double 
indicator dilution; single-thermal,  single-thermal indicator dilution; ITBV, intrathoracic blood volume; EVLW, extravascular lung water 
volume. 
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Timepoint Baseline 
 
1 hour 
 
 
4 hours 
 
 
8 hours 
 
Li-thermal ITBV 
(ml kg-1) 24.5 (± 3.3) 29.0 (± 7.6) 26.0 (± 3.6) 25.7 (± 6.2) 
ICG-thermal 
ITBV 
(ml kg-1) 
27.5 (± 7.5) 25.5 (± 1.7) 27.0 (± 2.4) 25.5 (± 4.7) 
Single-thermal 
ITBV 
(ml kg-1) 
25.0 (± 6.2) 27.1 (± 5.1) 24.7 (± 8.7) 29.3 (± 5.7) 
Gravimetric 
EVLW volume 
(ml kg-1) 
 - -  -   8.3 (± 3.1) 
Li-thermal EVLW 
volume 
(ml kg-1) 
1.6 (± 3.1) 0.4 (± 4.4) 3.7 (± 5.5) 8.7 (± 3.9) 
ICG-thermal 
EVLW volume 
(ml kg-1) 
4.5 (± 2.0) 6.7 (± 4.5) 5.4 (± 3.5) 7.4 (± 3.5) 
Single thermal 
EVLW volume 
(ml kg-1) 
12.1 (± 1.9) 13.8 (± 1.8) 13.8 (± 2.1) 18.8 (± 5.3) 
 
Table 4.6 Thoracic fluid volumes for the aortic balloon occlusion model (n=4) 
Data presented as mean (SD).  Li-thermal, lithium-thermal double indicator dilution; ICG-thermal, indocyanine green-thermal double 
indicator dilution; single-thermal,  single-thermal indicator dilution; ITBV, intrathoracic blood volume; EVLW, extravascular lung water 
volume.
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Mean EVLW volume as measured by gravimetry was 9.2 [±3.0] ml kg-1 (n=10). Bland-
Altman comparisons between Li-thermal, ICG-thermal, single-thermal and gravimetric 
EVLW volume measurements are presented in figure 4.1.  Linear regression analysis 
against the reference gravimetric measurements identified a poor correlation with each of 
the three indicator dilution techniques (Li-thermal r2 0.03, p=0.65; ICG-thermal r2 0.31, 
p=0.09; single-thermal r2 0.17, p=0.23) (figure 4.2). All three techniques showed 
considerable bias and limits of agreement when compared to the gravimetric technique 
(table 4.7).  Li-thermal and ICG-thermal underestimated EVLW volume (Li-thermal 7.45 
[±6.5] ml kg-1, ICG-thermal 7.7 [±3.4] ml kg-1, p=0.67) compared to the gravimetric 
technique, whereas there was overestimation with the single-thermal technique (17.3 [±6.9] 
ml kg -1, p<0.01). 
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Figure 4.1 Bland-Altman analysis of Li-thermal, ICG-thermal and single-thermal EVLW vs 
gravimetric EVLW. Dotted lines indicate bias and limits of agreement. 
EVLW, extravascular lung water volume; Li-thermal, lithium-thermal double indicator dilution; ICG-thermal, indocyanine green-
thermal double indicator dilution; single-thermal, single thermal indicator dilution
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Figure 4.2 Linear regression analysis of Li-thermal, ICG-thermal and single-thermal EVLW vs 
gravimetric EVLW  
Dotted lines indicate 95% confidence intervals for gradient. EVLW, extravascular lung water volume; Li-thermal, lithium-thermal 
double indicator dilution; ICG-thermal, indocyanine green-thermal double indicator dilution; single-thermal, single thermal indicator 
dilution
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 Li-thermal ICG-thermal single-thermal 
Bias (ml kg-1) -1.8 -1 8.5 
LOA (ml kg-1) ±13.1 ±6.6 ±14.5 
 
 
Table 4.7 Bias and limits of agreement of Li-thermal, ICG-thermal & single-thermal v gravimetric 
EVLW.   
LOA, limits of agreement; Li-thermal, lithium thermal double indicator dilution; ICG-thermal, indocyanine green-thermal double 
indicator dilution; single-thermal,  single thermal indicator dilution; ITBV, intrathoracic blood volume; EVLW, extravascular lung water 
volume 
 
 
Comparison of Li-thermal and single-thermal measurements of EVLW volume to the ICG-
thermal technique demonstrated considerable variability for both techniques. However 
there was notable overestimation with the single-thermal technique. Bland-Altman analysis 
is shown in figure 4.3.  
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Figure 4.3 Bland-Altman analysis of Li-thermal and single-thermal EVLW vs ICG-thermal EVLW. 
Dotted lines indicate bias and limits of agreement. 
EVLW, Extravascular lung water volume; Li-thermal, Lithium thermal double indicator dilution; ICG-thermal, Indocyanine Green-
thermal double indicator dilution; single-thermal, single thermal indicator dilution.
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Both the Li-thermal and single thermal techniques significantly underestimated 
measurement of ITBV with considerable variability when compared to the ICG-thermal 
technique, as shown in figure 4.4. 
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Figure 4.4 Bland-Altman analysis of Li-thermal and single-thermal ITBV vs ICG-thermal ITBV. 
Dotted lines indicate bias and limits of agreement. 
ITBV, Intrathoracic blood volume; Li-thermal, Lithium thermal double indicator dilution; ICG-thermal, Indocyanine Green-thermal 
double indicator dilution; single-thermal, single thermal indicator dilution.
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Lithium indicator dilution measurements of cardiac output compared well to those taken 
with the PA catheter whilst both ICG-thermal and single thermal measurements were 
significantly greater (figure 4.5, n=40).   Comparison between lithium and the single-
thermal techniques with ICG-thermal double indicator dilution showed considerable 
inaccuracy and variability (see table 4.8). 
 
 Li-thermal single-thermal 
Bias (l min-1) -1.5 -1.0 
LOA (l min-1) ±2.65 ±1.95 
 
Table 4.8 Bias and limits of agreement of Li-thermal & single-thermal v ICG-thermal CO.   
LOA, limits of agreement; Li-thermal, lithium thermal double indicator dilution; ICG-thermal, indocyanine green-thermal double 
indicator dilution; single-thermal,  single thermal indicator dilution; CO, cardiac output. 
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Swan-Ganz v ICG-thermal CO.
Bias 1.78 l min-1(±1.4), 95% limits of
agreement ± 2.7 l min-1.
Swan-Ganz v Single-thermal CO.
Bias 1.26 l min-1(±1.4), 95% limits of
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Figure 4.5 Bland-Altman analysis of Li-thermal, ICG-thermal and Single-thermal CO vs PA catheter 
CO. Dotted lines indicate bias and limits of agreement. 
CO, cardiac output; PA catheter, pulmonary artery catheter; Li-Thermal, lithium thermal double indicator dilution; ICG-thermal, 
indocyanine green-thermal double indicator dilution; Single-thermal, single thermal indicator dilution 
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4.4 Discussion 
4.4.1 Summary of findings 
When compared to the gravimetric method, the Li-thermal and ICG-thermal techniques 
demonstrated acceptable accuracy, but the wide limits of agreement suggested poor 
reliability. The single-thermal technique systematically over-estimated EVLW, with 
unacceptably wide limits of agreement signifying very poor reliability.   
 
4.4.2 Comparison to previous work 
The gravimetric technique has been used to measure EVLW volume in a number of 
laboratory models of acute lung injury (ALI) and sepsis.47,48,61,64,114  These studies used 
either intravenous lipopolysccharide to induce a septic response or direct instillation of 
oleic acid to induce ALI.  Consistent with these studies, we found that sepsis and ALI were 
associated with an increased EVLW volume, (9.2 [±3.0] ml kg-1), compared to sham 
operated animals (6.6 [±0.45] ml kg-1).61 Reported EVLW as measured with the ICG-
thermal technique in control animals (3.9 [±1.2] ml kg-1) is comparable with the pre-
intervention measurement in this study (4.8 [±2.1] ml kg-1).47  Other studies have used 
Bland-Altman analysis to compare EVLW volume measurement using ICG-thermal double 
indicator dilution with gravimetry.47,48 These investigators reported a bias of 5.8 (±7.7) ml 
kg-1 47 and 5.2 (±1.8) ml kg-1 48, figures which are comparable with the ICG-thermal data 
from this study.   
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EVLW volume determined by the Li-thermal and ICG-thermal techniques (7.45 (±6.5) and 
7.7 (±3.4) ml kg -1 respectively) were lower than those measured by gravimetry (9.2 [± 3.0] 
ml kg-1).  This is consistent with a report suggesting that the ICG-thermal dilution technique 
may underestimate EVLW compared to gravimetry.115   
 
4.4.3 Limitations of this study 
There are several potential limitations of this study.  Whilst manufacturers’ instructions 
were meticulously followed, it is possible that these techniques perform less well in 
animals than in humans.  Moreover, in the visceral ischaemia model, ICG-thermal and 
single-thermal catheters had to be placed more proximally via the carotid artery, not the 
femoral artery as would be standard practice.  It could be argued however, that this would 
lead to more accurate measurements of ITBV and hence EVLW, as the catheter tips are 
sited within the thoracic cavity in the arch of the aorta. Ideally, the indicator sampling point 
should be at the border of the thoracic cavity to ensure the measured value of MTT is as 
close as possible to the true physiological value. The indocyanine green-thermal indicator 
dilution system utilises a thermistor tipped fibreoptic arterial catheter inserted 
percutaneously via the femoral artery to lie at the level of the diaphragm. The technology 
used to perform lithium indicator dilution measurement of ITBV however, uses an external 
sensor attached to a peripheral arterial catheter rather than an internal sensor within a large 
artery. Consequently, for lithium indicator dilution, the measured value of MTT 
incorporates the true value and two additional values. The first of these is the time taken for 
the indicator to travel from the margin of the thoracic cage to the arterial catheter. The 
second value is the time taken for the indicator to transit from the catheter to the lithium 
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sensor, a value known to be 13.3 seconds. A bench study demonstrated that the time taken 
for an indicator bolus to transit the distance from the thoracic cavity border to a peripheral 
artery should be no more than two seconds.116 This assumed constant delay was 
incorporated into the calculation of ITBV and hence EVLW.  
 
The underestimation of EVLW volume by indicator dilution may be greater in the presence 
of ALI, perhaps due to redistribution of pulmonary blood flow away from oedematous 
areas which is thought to limit indicator diffusion and the consequent detection of 
oedema.47-50 Another possible explanation is the inability of the indicator to penetrate all 
lung tissue, particularly congested alveoli, in one trans-pulmonary circulation time. Use of 
positive end-expiratory pressure (PEEP) during mechanical ventilation has also been shown 
to affect the accuracy of EVLW volume measurement by indicator dilution.51 In addition, 
other studies have suggested that increased cardiac output can result in underestimation of 
EVLW by ICG-thermal dilution 52,53, although there is evidence that resolution of specific 
technical problems with the equipment can eliminate this error.54 More recent work has 
demonstrated that thermal indicator loss from oedematous lungs does not affect the 
accuracy of cardiac output measurement by indicator dilution.117  
 
The use of post-mortem gravimetry as the reference method for evaluating EVLW has 
several limitations.34,118 It is predominantly an experimental technique, and being a post-
mortem method, only one measurement is possible. The comparison of gravimetric values 
for EVLW volume with results obtained using other techniques can be influenced by the 
time elapsed from death to removal of the lungs, and by pathophysiological changes in the 
lungs after cardiac arrest. Thus, the gravimetric technique can underestimate EVLW 
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volume because of partial reabsorption of fluid before excision of the lungs. If this were the 
case, accuracy of the double indicator dilution techniques would worsen whereas accuracy 
of the single-thermal technique might be enhanced. 
 
4.4.4 Potential sources of error 
Estimation of EVLW volume by any indicator dilution technique requires accurate 
measurement of both MTT and CO.  Measurement of CO using lithium indicator dilution 
has been well validated in both humans and animals in a variety of situations and compares 
well with PA catheter derived values of CO (Bias +0.24 [±1.65] l min-1). 87,91,92,119-121 
Comparison of CO measurement by the Li-thermal and ICG-thermal techniques revealed 
considerable bias and LOA (-1.5 [±2.7] l min-1) which was also apparent in the comparison 
of ITBV determined by the same techniques (Bias -7.3 [±16.4] ml kg-1). It is therefore 
reasonable to assume that the observed differences values for ITBV and hence EVLW are 
at least in part due to the differences in CO measurement, given that the ICG-thermal 
technique compared poorly to the PA catheter (Bias +1.8 [±1.4] l min-1). However there 
were also observed differences in the MTT of the two indicators (Bias 0.1 [± 9.9] sec) 
suggesting indicator transit time to the lithium sensor, most likely from the thoracic border 
to the arterial catheter, contributed to the observed variability of ITBV and hence EVLW 
volume measurement. 
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4.4.5 Conclusions 
There were clinically relevant differences between EVLW volume measurements obtained 
with three in vivo indicator dilution techniques and the gravimetric method. Whilst none of 
the techniques could be considered ideal, the double indicator methods appear to be more 
accurate than the single-thermal indicator technique.  Further investigation of the prototype 
Li-thermal technology and comparison with ICG-thermal double indicator dilution in 
human subjects might improve accuracy and precision. 
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Chapter 5 
Estimation of extra-vascular lung water volume 
measurement by lithium-thermal indicator dilution in 
man: Comparison of two clinical techniques 
5.1 Introduction 
 
In the proof of concept study, the measurement of intra-thoracic blood volume (ITBV) by 
trans-pulmonary lithium indicator dilution appeared feasible (chapter 3). The results of this 
pilot study suggested that this method might allow accurate measurement of ITBV. 
However, in the porcine model of acute lung injury, both existing indicator dilution 
methods of EVLW volume measurement and the prototype Li-thermal method compared 
poorly to the post mortem gravimetric technique (chapter 4). Given the initial promise of 
the clinical proof of concept study, confirmation of the findings of the laboratory study 
were required in man. From the data generated by the ICG-thermal technique it is also 
possible to assess measured versus derived values of ITBV and EVLW and whether the 
GEDV:ITBV relationship is valid. 
 
The aim of this study was to compare the indocyanine green-thermal (ICG-thermal), 
lithium-thermal (Li-thermal) and single-thermal indicator dilution techniques of EVLW 
volume measurement in patients following elective cardiac surgery with cardio-pulmonary 
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bypass. The GEDV:ITBV relationship used by the commercially available single-thermal 
device to derive EVLW was also examined (see section 2.2). 
 
5.2 Methods 
5.2.1 Patients 
This single centre, observational study was prospectively approved by the Local Research 
Ethics Committee. Patients aged over 50 years undergoing elective cardiac surgery with 
cardio-pulmonary bypass were eligible for recruitment according to pre-defined criteria. 
Patients were screened for eligibility prior to surgery, and written informed consent 
obtained.  Exclusion criteria were refusal of consent, concurrent lithium therapy, pregnancy 
and weight less than 40 kg. Patients with acute arrhythmias, severe peripheral vascular 
disease, significant cardiac valvular regurgitation and intra-aortic balloon counterpulsation 
were also excluded as these conditions could affect indicator forward flow. 
 
5.2.2 Clinical Management 
Anaesthetic and cardiopulmonary bypass practices were standardised as described for the 
pilot study, chapter 3, section 3.2.2. An 18G femoral arterial sheath was sited on arrival to 
the Intensive Care Unit (ICU) through which a COLD-Z catheter (PV 2024 4FG; Pulsion 
Medical Systems, Munich, Germany) could be positioned at the level of the diaphragm for 
ICG-thermal indicator dilution measurements (figures 2.4 & 2.8). Patients were managed 
on the ICU following surgery, where sedation was discontinued and the tracheal tube 
removed by clinical staff according to local protocols. 
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5.2.3 ITBV & EVLW measurement using lithium indicator dilution 
Paired measurements were taken 1, 2, 4 and 24 hours after surgery using the methods 
described in chapter 2, section 2.3 and chapter 3, section 3.2.3.  EVLW volumes were 
calculated using the method described in section 4.2.6. 
 
5.2.4 EVLW& ITBV measurement using the ICG-thermal method 
ITBV, ITTV and EVLW volume measurements were made using the ICG-thermal indicator 
dilution technique. (COLD-Z, Pulsion Medical Systems, Munich) detailed in chapter 2, 
section 2.1.111 20ml of iced 5% dextrose solution containing 25mg ICG was injected via the 
central venous catheter. Changes in temperature and ICG concentration were detected using 
a thermistor tipped fibreoptic arterial catheter (Pulsiocath PV 2024 4F, Pulsion Medical 
Systems) attached to the COLD-Z monitor. 
 
5.2.5 Derived single thermal indicator dilution ITBV & EVLW  
Measurement of intrathoracic blood volume using single thermal indicator dilution 
(ITBVthermal) relies on the hypothesis that ITBVthermal is 25% greater than global end 
diastolic volume (GEDV).58 GEDV is the difference between intrathoracic thermal and 
pulmonary thermal volumes (ITTV & PTV) as determined by analysis of the thermal curve 
using the Stewart-Hamilton and Newman equations.36,37,43 This allows EVLWthermal to be 
derived from ITTV & ITBVthermal by subtraction.  GEDV and ITBV are measured as part of 
the ICG-thermal technique, therefore allowing comparison of measured and derived values 
of ITBV and EVLW. 
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5.2.6 Statistical analysis 
ITBV was chosen for sample size calculations as this is the key measurement difference 
between the Li-thermal and ICG-thermal techniques. Assuming a type I error rate of 5% 
and a type II error rate of 10%, it was estimated that 20 patients would be required to detect 
a change in ITBV of 1.5 ml kg-1, standard deviation (SD) 4 ml kg-1. Data are presented as 
mean (SD) where normally distributed and median (IQR) where not normally distributed. 
The comparison between ITBV & EVLW measured with lithium indicator dilution, ICG-
thermal double indicator dilution and derived data was evaluated using the technique of 
Bland and Altman. Percentage error was calculated according to the method reported by 
Critchley, as the limit of agreement (±2 SD) of the bias divided by the mean CO from the 
two methods under comparison.113  Parametric data were compared using the unpaired t-test 
and non-parametric data were compared with the Mann-Whitney test. Differences in the 
measurement of EVLW, ITBV and CO made with each technique at each timepoint were 
compared using repeated measures analysis of variance (ANOVA) with Tukey’s correction. 
Comparison of ITBV and MTT with temperature were analysed by linear regression. 
Significance was set at p<0.05. 
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5.3 Results 
5.3.1 Patient and equipment data 
 
Seventeen patients were recruited between July and September 2007 after which the supply 
of specialist COLD-Z arterial catheters was exhausted and further catheters could not be 
sourced from the UK supplier. There was also failure of the COLD-Z machine caused by 
worn-out components in the infra-red light emitting hardware. This was irretrievable as 
repair or replacement parts are not available. The baseline characteristics of these patients 
are presented in table 5.1 with physiological data shown in table 5.2. After four patients, the 
final measurement timepoint had to be moved from 24 to 6 hours owing to problems 
obtaining good quality ICG curves with patient movement on awakening from surgery and 
the clinical need to remove the femoral arterial catheter for post-operative mobilisation. 16 
ICG measurements were excluded because of the poor quality of the ICG indicator dilution 
curve which did not allow reliable analysis of ITBV or MTT. The COLD-Z machine 
defaulted to the thermal curve in these situations for the measurement of CO, ITBV and 
EVLW. This left a total of 52 paired comparisons with good quality data.  There were no 
poor quality lithium curves on post-hoc analysis to affect MTT measurement or CO 
derivation. 
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n 17 
Age 69 years (±9) 
Gender 15 male 
Weight 82 kg (±19) 
Parsonnet score 10 (±8) 
Duration of cardio-pulmonary bypass 74 minutes (±17) 
Coronary artery bypass graft 13 
Aortic valve replacement 2 
Coronary artery bypass graft and aortic 
valve replacement as combined 
procedure 
2 
 
Table 5.1 Baseline patient characteristics  
  
Data presented as mean (SD) 
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Time 1 hours 2 hours 4 hours 6 hours p 
MAP (mm Hg) 71  (±4) 71 (±7) 79 (±9)** 75 (±8) <0.05 
CVP (mm Hg) 12 (±4) 12 (±3) 13 (±4) 11 (±3) 0.52 
PaO2 (kPa) 
14.8 
[13.1-18.5] 
15.3 
[13.6-19.9] 
15.2 
[11.5-17.8] 
13.7 
[11.5-14.8] 0.22 
PaO2:FiO2 (kPa) 34 (±10) 37 (±7) 36 (±14) 34 (±9) 0.9 
Core Temperature 
(oC) 
36.3 
(±0.5) 
36.5 
(±0.6) 
36.9* 
(±0.5) 
37.2*,** 
(±0.5) <0.0001 
Peripheral 
temperature (oC) 
30.6 
(±2.0) 
31.6 
(±2.0) 
32.8* 
(±1.7) 
33.1* 
(±1.6) <0.05 
Temperature 
difference (oC) 
(Core-peripheral) 
5.4 (±2.2) 4.6 (±2.1) 3.9 (±1.8) 3.5 (±2.0) 0.05 
Cumulative fluid 
balance (ml) 
1903 
[1740-2631] 
2578 
[1969-2908] 
3015* 
[2294-3379] 
3457* 
[2621-4506] <0.001 
 
Table 5.2 Physiological variables (n=14).  
Data presented as mean (SD) or median [IQR]. MAP, mean arterial pressure; CVP, central venous pressure. * indicates significant 
changes with respect to 1 hour values. ** indicates significant changes with respect to 2 hour values.
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5.3.2 Thoracic volume and cardiac output data 
EVLW data is presented in table 5.3 and figure 5.1. Mean EVLW volume as measured by 
the ICG-thermal technique was 4.6 (±1.9) ml kg-1 compared to 5.3 (±1.4) ml kg-1 for the 
single-thermal method. Measurements taken with the Li-thermal method were clearly 
erroneous  (-7.6 [±7.4] ml kg-1) and compared poorly to simultaneous measurements made 
using the ICG-thermal method (Bias +13.2 [±14.4] ml kg-1). For the single-thermal method, 
there was more acceptable bias, but limits of agreement remained poor (Bias -0.3 [±2.3] ml 
kg-1). Agreement between the ICG-thermal and single thermal methods in terms of 
percentage change in EVLW between time points was also poor (Bias 2.2 % [72%]). 
 
ITBV data is presented in table 5.3 and figure 5.2. Mean ITBV measured by lithium 
dilution was 1276 (±367) ml m-2 compared to 859 (±149) ml m-2 by the ICG-thermal 
method. Comparison between the two techniques, lithium versus ICG-thermal, showed 
significant bias (407ml m-2) and wide limits of agreement (±717). The ITBV data obtained 
using ICG-thermal double indicator dilution was considerably lower during the post-
operative period than those obtained with lithium indicator dilution. However the trend in 
values obtained by ICG-thermal double indicator dilution increased during this period in 
contrast to decreasing values for lithium (figure 5.3). Measurements from the single-
thermal method (830 [±169] ml m-2) compared better to the ICG-thermal technique (859 
[±149] ml m-2) with minimal bias and LOA (25.3 [±108] ml m-2).  
 
Errors in the Li-thermal data resulted from a considerable over-estimate of ITBV, due in 
turn to an over-estimate of MTT (see table 5.4). Analysis of mean transit time (MTT) 
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measurement demonstrated considerable inconsistencies (Bias 12.8 [±13] sec) (figure 5.4). 
Cardiac index, the other component variable of ITBV was similar between the two 
techniques (Bias 0.39 [±0.9] l min-1 m-2, p<0.0001, figure 5.5). Analysis of individual time 
points suggested the ITBV and MTT difference decreased over time (477 to 289ml m-2, 
p=0.16 and 16.0 to 10.6sec respectively, p<0.05, figures 5.6 & 5.7).  Core and peripheral 
temperatures significantly increased over the same time period, p<0.001 & p<0.05 
respectively (figures 5.8 & 5.9).  There was no correlation between core:peripheral 
temperature difference and the measured ITBV (r2=0.004) or MTT difference (r2=0.05).  
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Table 5.3 Measurements of EVLW and ITBV at individual time points using three different methods of 
indicator dilution (n=14).  
Data presented as mean (SD). Li-thermal: lithium-thermal indicator dilution; ICG-thermal: indocyanine green-thermal indicator dilution;. 
Single-thermal, single-thermal indicator dilution; ITBV, intrathoracic blood volume; EVLW, extravascular lung water volume. 
 
 
 
Time 1 hour  2 hours 4 hours 6 hours 
ICG-thermal EVLW 
(ml kg-1) 5.6 (±2.1) 4.6 (±1.9) 5.4 (±2.0) 4.8 (±1.4) 
Li-thermal EVLW 
(ml kg-1) -7.8 (±5.6) -9.9 (±5.6) -7.9 (±10.5) -6.6 (±7.0) 
Single-thermal EVLW 
(ml kg-1) 5.5 (±1.7) 4.9 (±1.4) 5.6 (±1.4) 5.3 (±1.0) 
ICG-thermal ITBV 
(ml m-2) 794 (±165) 856 (±156) 880 (±140) 915 (±146) 
Li-thermal ITBV 
(ml m-2) 1271 (±336) 1318 (±350) 1309 (±407) 1203 (±311) 
Single-thermal ITBV 
(ml m-2) 777 (±180) 827 (±129) 880 (±175) 880 (±170) 
ITBV difference (ml m-2) 
(Li-ICG) 477 (±288) 462 (±298) 429 (±401) 289 (±318) 
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Figure 5.1 Bland-Altman analysis of Li-thermal and single-thermal EVLW vs ICG-thermal EVLW. 
Dotted lines indicate bias and limits of agreement. 
EVLW, Extravascular lung water volume; Li-thermal, Lithium thermal double indicator dilution; ICG-thermal, Indocyanine Green-
thermal double indicator dilution; single-thermal, single thermal indicator dilution.
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Figure 5.2 Bland-Altman analysis of Li-thermal and single-thermal ITBV vs ICG-thermal ITBV. 
Dotted lines indicate bias and limits of agreement. 
ITBV, Intrathoracic blood volume; Li-thermal, Lithium thermal double indicator dilution; ICG-thermal, Indocyanine Green-thermal 
double indicator dilution; single-thermal, single thermal indicator dilution 
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Table 5.4 Measurements of mean indicator transit time (MTT), cardiac index and temperature at 
individual time points.  
Data presented as mean (SD). Li-thermal: lithium-thermal indicator dilution; ICG-thermal: indocyanine green-thermal indicator dilution. 
Time 1 hour 2 hours 4 hours 6 hours 
Li-thermal MTT 
(seconds) 35.1 (±8.1) 33.2 (±4.6) 29.4 (±7.2) 28.7 (±5.5) 
ICG-thermal MTT  
(seconds) 19.0 (±3.4) 18.5 (±3.6) 17.8 (±3.3) 18.1 (±3.4) 
MTT difference (seconds) 
(Li-ICG) 16.1 (±8.5) 14.5 (±4.4) 11.5 (±6.8) 10.6 (±5.8) 
Li-thermal cardiac index  
(l min-1 m-2) 2.3 (±0.5) 2.4 (±0.6) 2.6 (±0.7) 2.6 (±0.7) 
ICG-thermal cardiac index  
(l min-1 m-2) 2.5 (±0.7) 2.8 (±0.6) 3.0 (±0.6) 3.1 (±0.6) 
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Figure 5.3 ITBV measured by Li-thermal and ICG-thermal at different timepoints. Data presented as 
mean (SD).  
Shaded area indicates normal value of ITBV. 
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Figure 5.4 Bland-Altman analysis of lithium MTT versus ICG MTT.  Bias 12.8 seconds, 95% limits of 
agreement ±13 seconds.   
Dotted lines indicate bias and limits of agreement. MTT, mean transit time 
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Figure 5.5. Bland-Altman analysis of lithium cardiac index versus ICG cardiac index.  Bias 0.39 l min-1 
m-2, 95% limits of agreement ±0.9 l min-1 m-2.   
Dotted lines indicate bias and limits of agreement. 
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Figure 5.6 Difference in ITBV at different time-points. Data presented as mean (SD).  
Changes in ITBV difference were not significant (p=0.46, repeated measures ANOVA) 
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Figure 5.7 Difference in MTT at different time-points. Data presented as mean (SD).  
Changes in MTT difference were significant (p<0.05, repeated measures ANOVA). * indicates significant changes with respect to 1 hour 
values. 
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Figure 5.8 Core temperature change at different time-points. Data presented as mean (SD).  
Changes in core temperature were highly  significant (p<0.001, repeated measures ANOVA). * indicates significant changes with respect 
to 1 hour values. 
 
 
1 h
ou
r
2 h
ou
rs
4 h
ou
rs
6 h
ou
rs
28
30
32
34
36
Pe
ri
ph
er
al
  T
em
pe
ra
tu
re
  (
o c
)
* *
 
Figure 5.9 Peripheral temperature change at different time-points. Data presented as mean (SD).  
Changes in peripheral temperature were significant (p<0.05, repeated measures ANOVA). * indicates significant changes with respect to 
1 hour values. 
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5.4 Discussion 
5.4.1 Summary of findings 
This study describes a comparison between measurements of EVLW obtained with the 
prototype lithium-thermal indicator dilution and derived single thermal techniques and the 
accepted clinical reference standard of ICG-thermal double indicator dilution. The principle 
finding of this study was that neither the prototype Li-thermal nor the single thermal 
methods provided acceptable measurements of EVLW volume when compared to the ICG-
thermal technique. Whilst there was minimal bias associated with the single-thermal 
method, limits of agreement were approximately 45% of the normal value of EVLW 
volume. The Li-thermal method performed very poorly due to the over-estimation of mean 
indicator transit time using an external lithium ion electrode. These data suggest that neither 
the Li-thermal nor the single thermal method provide measurements of EVLW volume that 
are sufficiently accurate to guide clinical interventions in individual patients. 
  
5.4.2 Sources of error 
Comparison of the Li-thermal and ICG-thermal techniques to the gravimetric measurement 
of EVLW volume in a porcine model of acute lung injury revealed much closer agreement 
between the two methods. However, in this investigation, the external lithium ion electrode 
was attached to a centrally placed femoral or carotid arterial catheter. These data suggest 
that, for accurate EVLW volume measurement by indicator dilution, blood must be 
sampled via an arterial catheter sited within the aorta at the level of the diaphragm. ITBV is 
a product of CO and MTT, therefore the recorded error must be due to difficulties and 
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potential differences in measuring these two variables.  Whilst measurements of cardiac 
output were similar for the two techniques, there were considerable differences in MTT. As 
discussed in the methods, for lithium indicator dilution, the measured value of MTT 
incorporates the true value and two additional values. Flow through the external tubing to 
the sensor is regulated by the peristaltic pump and can thus be regarded as constant. Data 
from a previous study suggested that the additional time from the thoracic cage to the radial 
artery would be approximately two seconds, and this was incorporated into the 
calculations.116 However, this assumption was clearly incorrect, the delay not only being 
longer but also variable.  This prevented accurate adjustment of the calculation of MTT and 
hence ITBV.   
 
The variable and inconsistent transit time of the lithium indicator bolus in the peripheral 
circulation was clearly unexpected. Interestingly however, there appeared to be a reduction 
in the ITBV difference measured by the two techniques as the study progressed. This 
coincided with increasing trends in CI (2.4 – 2.8 l min-1 m-2, p=0.2), core temperature (36.3 
– 37.2oC, p<0.0001) and peripheral temperature (30.6 – 33.1oC, p<0.05).  Unfortunately 
there was no correlation between ITBV or MTT difference and the core/peripheral 
temperature difference, indicating that no allowance or adjustment could be made to the 
algorithm to improve accuracy or reliability.  
Consequently it appears that ITBV measurements using lithium indicator dilution detected 
by an external sensor at the radial artery are unreliable in this patient population due to 
variable and unpredictable indicator transit time in the peripheral circulation.  
 
 131
5.4.3 Derived ITBV and EVLW volumes 
Single thermal indicator dilution measurement of ITBV (as derived from the assumption 
that ITBV=(GEDV*1.25)-28.4) appears to correlate well with ICG-thermal double 
indicator dilution (Bias 25.3ml m-2), in addition to showing minimal variability 
(LOA±108). However, EVLW calculation using the derived value of ITBV, showed 
considerable variability (bias -0.27ml kg-1 LOA±2.31), although agreement between the 
two methods was reasonable. Findings of a previous study comparing the ICG-thermal and 
single-thermal methods of EVLW volume measurement were inconsistent. 59 Similarly, in 
this investigation, there were wide limits of agreement between the single-thermal and 
ICG-thermal methods. In some cases, adjustment of the single-thermal algorithm is 
required to account for the individual circumstances of the experiment (as discussed in 
section 1.4.3).60-62 The credibility of using this technique to make important clinical 
decisions regarding ventilation and fluid therapy in critically ill patients is therefore 
questionable.  
 
5.4.4 Conclusions 
Both the prototype Li-thermal and the single thermal measurements of EVLW volume 
showed poor agreement with those obtained using the ICG-thermal method. Poor 
agreement between the ICG-thermal and Li-thermal techniques appears to be due to 
inaccurate measurement of lithium mean transit time using an external sensor attached to a 
peripheral radial arterial catheter. Derived single-thermal EVLW volumes, whilst 
demonstrating reasonable agreement, showed considerable variability. These findings 
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suggest that trans-pulmonary indicator dilution measurements of ITBV and EVLW volume 
are not sufficiently accurate to safely guide clinical interventions in individual patients. 
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Chapter 6 
Dye curve analysis – a comparison of automated versus 
manual systems 
 
6.1 Introduction 
Throughout this series of studies, all comparisons of thoracic volumes measured by 
indicator dilution, namely ITBV and EVLW, have used data generated by computer 
analysis of the dilution curve constructed by the three techniques; lithium, ICG-thermal and 
single thermal. Comparison of the lithium and ICG-thermal techniques in man post-cardiac 
surgery showed unacceptable bias and LOA, leading to the conclusion that the 
measurement of ITBV and EVLW using the lithium indicator dilution technology in its 
existing form is invalid.  
 
The ICG-thermal technique uses computer hardware and software analysis that is almost 20 
years old. It was the data generated from this dye curve analysis that was compared to the 
lithium indicator dilution system which is subjected to a continuing programme of 
computer hardware and software development.  It is possible that the error observed in the 
clinical study was due in part to inaccurate indicator dilution curve analysis, potentially for 
both techniques. The aim of this study was to compare cardiac output and thoracic fluid 
volume data derived manually, with that obtained automatically, to assess any potential 
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sources of error. I would like to thank Dr Chris Wolff for the considerable input and 
support he provided with the analysis and methodology described in this chapter. 
 
6.2 Background 
Measurement of ITBV and EVLW volume using indicator dilution has its origins in the 
derivation of cardiac output, a necessary part of the calculations in ascertaining these 
volumes. Measurement of cardiac output by indicator dilution requires knowledge of the 
indicator dose given and the area under the concentration curve generated after passage in 
the blood to a recording device.  
A
DCO =
 
Equation 6.1 Derivation of cardiac output using indicator dilution  
CO, cardiac output; D, indicator dose; A, area under the indicator dilution curve 
 
Deriving the area under a dilution curve is complicated by re-circulating dye that causes 
distortion of the end of the curve. However this problem can be overcome by evaluating the 
early part of the downslope which is truly exponential (figure 6.1, upper curve).  
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Figure 6.1 Illustration of an indicator dilution curve with re-circulation.  
Dotted line highlights exponential part of the curve 
 
The area under such an exponential from a given time point, is the product of the 
concentration and the time constant, which is gained from the natural logarithm of the 
curve at this exponential point. The total area under the curve is thus (equation 6.2): 
∫ += 0 ).(
td
CdA τ
 
Equation 6.2 Evaluation of the area under an indicator dilution curve 
A, area under the indicator dilution curve; Td, timepoint up to exponential part of the curve; Cd, indicator concentration; τ, time constant 
 
Clearly manual integration and calculation of the area under the curve is laborious and 
would be impractical for routine clinical use. Computer software can quickly generate 
cardiac output data, as proven by the numerous devices available commercially for this 
purpose.  However, for the derivation of thoracic fluid volumes, automated systems have 
also to measure MTT. In the case of pulmonary blood volume derivation, the software also 
  136
has to calculate the downslope time by taking the natural logarithm of the curve and 
extrapolating a straight line to the x-axis (figure 6.1, bottom curve). It is important that 
automated dye curve analysis derives accurate and repeatable data as any measurement 
error, however small, will be multiplied throughout the process of calculating these 
volumes and could result in significant inaccuracy of the final figures.  
 
6.2 Dye curve analysis 
6.2.1 Introduction 
Measurements made in the present study were designed to examine CO and derived 
thoracic fluid volumes postoperatively in patients having cardiac operations for a variety of 
conditions. Both the LiDCO and COLD-Z machines can store data generated by each 
measurement, allowing comparison of the results reported by the machine algorithm and 
analyses of the dye curves made by hand from the stored recordings. This also allowed for 
examination of the relationship between ITBV and GEDV in a set of patients with different 
pathology from those studied in the paper by Sakka et al, which led to the development of 
the single-thermal indicator dilution technique.58 
 
6.2.1 ICG-Thermal indicator curve analysis 
The seventeen patients (fifteen male, two female) recruited for the clinical study had all the 
indicator dilution curves that were digitally stored, downloaded onto storage media for 
processing. The dye curve files were uploaded from the storage media into a laptop 
computer and imported into Cambridge Electronic display software files (CED, Cambridge, 
Spike 2, version 6.1.0) for display, and to allow conversion into text files for analysis in 
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Microsoft Excel spreadsheets. Text files for each time point were imported to Microsoft 
Excel. There were values from five channels, only three of which contained recorded data; 
input temperature and output temperature allowing for generation of a thermal dye curve, 
and indo-cyanine green concentration for generation of the dye curve. Three time intervals 
are required to allow manual derivation of thoracic fluid volumes: 
 
1) Beginning of each dye curve (referred to as the toe of the curve). The thermal and 
ICG curve onset times were virtually identical.  
2) Mean transit times, MTTthermal and MTTICG.  
3) The time constant values for both thermal and ICG curves, which were independent 
of the timing of the input curve. 
6.2.1.1 Elimination of curve baseline drift 
The two raw dye curves (thermal and ICG) were plotted on separate spread sheets. In order 
to generate the thoracic fluid volume data, it was necessary to eliminate any baseline drift 
as this could have altered the shape of the curve, and hence the area under the curve and the 
true MTT. The baseline trend was fitted by copying the section of the baseline that looked 
most representative, fitting a linear regression line, and then generating a baseline around 
zero by subtraction (figure 6.2). 
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Figure 6.2 ICG dye curve after removal of baseline drift  
ICG, Indocyanine green. Left hand figure illustrates curve generated, using study patient data, having been downloaded from the COLD-
Z machine and imported into excel using Spike2 software with the baseline drift apparent (pink line). Right hand figure illustrates curve 
after adjustment to x-axis and removal of baseline drift.  
 
The adjusted plot then acted as the true curve for identification of: 
1) The onset of mixing; referred to as the toe (beginning) of the dye curve 
2) The area under the curve up to a point beyond the peak (A1) 
3) A logarithmic version of the curve to identify the exponential section of the 
downslope (linear part of the logarithmic curve) 
4) The area under the remaining part of the curve, not including recirculation (A2) 
5) Mean transit time – the timing of arrival of the integral at half the total area 
6.2.1.2 Deriving the area under the indicator dilution curve 
The procedure adopted to obtain the total area under the curve was relatively 
straightforward. The curve was essentially divided into two, A1 and A2. Area A1 is 
calculated by integrating from the toe, up to the time point 0.1s prior to timepoint v, which 
in this example would be 45.5 seconds. A2 is the part of the curve that includes 
recirculation of dye which needs to be excluded (See figure 6.3).  
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Figure 6.3 Illustration of areas A1 & A2.  Total AUC = A1+A2. 
AUC, Area under the curve; ICG, Indocyanine Green 
 
This is achieved by adopting a logarithmic version of the curve, inspecting the down-
sloping section for a linear section, then fitting a linear regression line (figure 6.4 – pink 
line).  
y = -0.186x + 5.1293
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Figure 6.4 Logarithmic ICG dye curve allowing generation of τ and required time points for curve area 
calculation 
ICG, Indocyanine Green; τ, time constant. In this case, v is 45.6 seconds.  
A2A1 
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The slope of this line is the rate constant, and its reciprocal the time constant (τ). Taking the 
value at the time point immediately following A1 (v) then: 
τ.2 vA =  
Equation 6.3 Calculation of A2 
A2, area under curve from truly exponential point; v, time point at the start of exponential curve decay; τ, time constant.  
Therefore the total area under the curve (AUC) is the sum of A1 and A2. 
∫
−
+=
0
1.0
).(
v
vAUC τ
 
Equation 6.4 Derivation of total area under the indicator dilution curve 
AUC, area under the curve; v, time point at the start of exponential curve decay; τ, time constant.  
 
6.2.1.3 Derivation of MTT and CO 
The calculation of the AUC allows derivation of MTTicg and MTTthermal as this is the time at 
half the total curve area. The thermal curve was used to derive cardiac output with 
AUCthermal and MTTthermal calculated in identical fashion to that of ICG. The value used as 
the dose consisted of the input (injectate) volume multiplied by the difference between the 
input and output temperature. Once the thermal dose had been divided by the total area 
under the thermal curve, the values from 12 time points on three patients were compared 
with those given by the machine (algorithm). This gave a scaling factor K (0.0002) which 
was then used for all calculations of cardiac output and hence, calculation of all thoracic 
fluid volumes. 
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AUC
KTITBVICO .60)..( −=  
Equation 6.5 Calculation of cardiac output using the thermal dilution curve 
CO, cardiac output; VI, volume of injectate; TB, blood temperature; TI, injectate temperature; AUC, area under the curve; K, scaling 
factor 
 
6.2.2 Lithium indicator curve analysis 
The principles applied to ICG-thermal curve analysis also apply to the analysis of lithium 
curves but with some additional factors that needed to be considered. Initially, the raw 
lithium curves had a near zero baseline trend fitted by copying the section of the baseline 
that looked most representative, fitting a linear regression line, and then generating a 
baseline around zero by subtraction in similar fashion to the ICG analysis (figure 6.5).
y = -0.1598x + 1626.8
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Figure 6.5 Lithium indicator curve after removal of baseline drift  
Left hand figure illustrates curve generated, using study patient data, once downloaded from the LiDCO machine and imported into excel 
with baseline drift apparent (pink line). Right hand figure illustrates curve after adjustment to x-axis and baseline drift removal. 
  
Subsequent conversion of Li units into mV via a machine generated calibration factor 
(figure 6.6) allows derivation of Li concentration in mM (LimM) and curve generation. 
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Figure 6.6 Lithium indicator curve demonstrating excess mV 
Li, Lithium; mV, millivolts. The excess mV generated by the lithium indicator bolus are incorporated into the following equation that 
incorporates the presence of Na+ in the plasma:  LimM = (10^ (Excess mV/61)* Li≡Na) - Li≡Na. [Li≡Na = 140*(Na+plasma/140)]. 
 
The calculation of the AUC is then similar to that for the ICG-thermal curves (see sections 
6.2.1.1 and 6.2.1.2) and so allows derivation of MTT ,CO (see equation 2.1) and hence 
ITBV.  
  143
6.3 Results 
Comparison of automated and manual dye curve analysis was possible for a total of 52 
paired lithium, ICG and thermal curves.  The key parameters examined were cardiac output 
(CO), mean transit time (MTT) and intrathoracic blood volume (ITBV). Automated and 
manual dye curve analysis of extravascular lung water (EVLW) as measured by the ICG-
thermal double indicator dilution system was also performed. 
Whilst there was minimal bias in the cardiac output data, it was interesting to observe a 
degree of variability for both techniques (machine v manual); Li bias -0.12l min-1, 95% 
LOA ±1.08, ICG-thermal bias -0.09l min-1, 95% LOA ±1.6 (figures 6.7 & 6.8). 
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Figure 6.7 Bland-Altman analysis of COmachine versus COmanual derived from lithium indicator dilution 
curves.  Bias –0.1l min-1, 95% limits of agreement ±1.04l min-1.   
Dotted lines indicate bias and limits of agreement. COmachine, Cardiac output derived from automated machine analysis. COmanual, Cardiac 
output derived manually. 
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Figure 6.8 Bland-Altman analysis of COmachine versus COmanual derived from indocyanine green-thermal 
double indicator dilution curves.  Bias –0.1l  min-1, 95% limits of agreement ±1.6l min-1.   
Dotted lines indicate bias and limits of agreement. COmachine, Cardiac output derived from automated machine analysis. COmanual, Cardiac 
output derived manually. 
 
Manual lithium indicator dilution curve analysis also demonstrated considerable bias and 
LOA in the measurement of the MTT (Bias -2.8sec, 95% LOA ±5.2), however the 
automated ICG-thermal MTT data was much more accurate and less variable for both the 
ICG and thermal curves (ICG bias 1.7sec, 95% LOA ±1.1sec; Thermal bias 2.3sec, 95% 
limits of agreement ±2.4) - figures 6.9 - 6.11.  
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Figure 6.9 Bland-Altman analysis of MTTmachine versus MTTmanual derived from lithium indicator 
dilution curves.  Bias -2.8sec, 95% limits of agreement ±5.2sec.   
Dotted lines indicate bias and limits of agreement. MTTmachine, Mean Transit Time derived from automated machine analysis. MTThand, 
Mean Transit Time derived manually. 
0 5 10 15 20 25 30
0
5
10
Average MTTicg (sec)
D
iff
er
en
ce
 in
 M
TT
ic
g (
se
c)
 
Figure 6.10 Bland-Altman analysis of MTTmachine versus MTTmanual derived from indocyanine green 
indicator dilution curves.  Bias 1.7sec, 95% limits of agreement ±1.6sec.   
Dotted lines indicate bias and limits of agreement. MTTmachine, Mean Transit Time derived from automated machine analysis. MTThand, 
Mean Transit Time derived manually. 
0 5 10 15 20 25 30 35
0
5
10
Average MTTthermal (sec)D
iff
er
en
ce
 in
 M
TT
th
er
m
al
 (s
ec
)
 
Figure 6.11 Bland-Altman analysis of MTTmachine versus MTTmanual derived from thermal indicator 
dilution curves.  Bias 2.3sec, 95% limits of agreement ±2.4sec.  
Dotted lines indicate bias and limits of agreement. MTTmachine, Mean Transit Time derived from automated machine analysis. MTThand, 
Mean Transit Time derived manually. 
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In keeping with the greater accuracy of the automated analysis compared to manual 
analysis of CO and MTT for the ICG-thermal technique, ITBV derivation was also more 
accurate than lithium indicator dilution (ICG-thermal bias 69ml m-2, 95% LOA ±145; Li 
bias -132ml m-2, 95% LOA ±396ml)- figures 6.12 & 6.13). ITTV analysis however 
revealed considerably less accuracy and more variability (bias 155ml m-2, 95% limits of 
agreement ±258ml m-2) – figure 6.14.   
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Figure 6.12 Bland-Altman analysis of ITBVmachine versus ITBVmanual derived from lithium indicator 
dilution curves.  Bias -132ml m-2, 95% limits of agreement ±396ml m-2.  Dotted lines indicate bias and limits of 
agreement. ITBVmachine, Intrathoracic blood volume derived from automated machine analysis. ITBVhand, Intrathoracic blood volume 
derived manually. 
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Figure 6.13 Bland-Altman analysis of ITBVmachine versus ITBVmanual derived from indocyanine green 
indicator dilution curves.  Bias 69ml m-2, 95% limits of agreement ±145ml m-2.  Dotted lines indicate bias and 
limits of agreement. ITBVmachine, Intrathoracic blood volume derived from automated machine analysis. ITBVhand, Intrathoracic blood 
volume derived manually. 
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Figure 6.14 Bland-Altman analysis of ITTVmachine versus ITTVmanual derived from thermal indicator 
dilution curves.  Bias 155ml m-2, 95% limits of agreement ±258ml m-2.   
Dotted lines indicate bias and limits of agreement. ITTVmachine, Intrathoracic thermal volume derived from automated machine analysis. 
ITTVhand, Intrathoracic thermal volume derived manually. 
 
Despite the automated ICG-thermal curve analysis functioning adequately for CO, MTT 
and ITBV calculation, the observed variability in the derivation of ITTV appears to impact 
on the derivation of EVLW considerably. The observed bias of automated versus manual 
analysis was 0.5ml kg-1, with 95% LOA ±1.3 (figure 6.15).   
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Figure 6.15 Bland-Altman analysis of EVLWmachine versus EVLWmanual derived from the mean transit 
times of indocyanine green-thermal indicator dilution curves.  Bias 0.5ml kg-1, 95% limits of agreement 
±1.3ml kg-1.   
Dotted lines indicate bias and limits of agreement. EVLWmachine, Extravascular lung water volume derived from automated machine 
analysis. EVLWhand, Extravascular lung water volume derived manually. 
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The equation for EVLW calculation can be rearranged such that it is the difference in the 
MTT of the thoracic fluid volumes, as measured by the ICG and thermal indicators, 
multiplied by the CO, rather than the difference in the fluid volumes themselves. This 
principle can be extended further when considering fluid volumes derived from analysis of 
the downslope time of the curves.  The volumes, PBV and PTV, which can be calculated 
from ICG and thermal curve analysis respectively, also allow EVLW volume derivation by 
the same principle. Hence the difference in Dst should yield similar EVLW volumes as the 
difference in MTT, with the time difference also being comparable. Linear regression 
analysis of the difference in MTT versus difference in Dst yielded reasonable correlation 
(R2=0.71, p<0.0001). However comparison of EVLW volume derived using MTT or Dst, 
whilst the bias was minimal (0.1ml kg-1), demonstrated considerable variability (95% LOA 
±2.4), figures 6.16 & 6.17.   
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Figure 6.16 Linear regression analysis of the difference in mean transit times versus the difference in 
downslope times derived from indocyanine green-thermal indicator dilution curves.  r2=0.71, p<0.0001.  
Dotted lines indicate 95% confidence intervals. MTTicg, Indocyanine green mean transit time. MTTthermal, Thermal indicator mean transit 
time. Dsticg, Indocyanine green downslope time. Dstthermal, Thermal indicator downslope time. 
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Figure 6.17 Bland-Altman analysis of EVLWMTT versus EVLWDst derived from indocyanine green-
thermal indicator dilution curves.  Bias 0.1ml kg-1, 95% limits of agreement ±2.4ml kg-1.   
Dotted lines indicate bias and limits of agreement. EVLWMTT, Extravascular lung water volume derived from mean transit time analysis. 
EVLWDst, Extravascular lung water volume derived from downslope time analysis 
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6.4 Discussion 
6.4.1 Summary of findings 
This study demonstrates that automated dye curve analysis is subject to error. The ICG-
thermal curve analysis is sufficiently accurate for the measurement of CO, MTT and ITBV. 
However, this accuracy is not maintained for all volumes, particularly when the thermal 
curve contributes to these calculations. The lithium indicator dilution curve software 
analysis is accurate for measurement of CO but unacceptably inaccurate when deriving 
MTT and ITBV. 
 
6.4.2 Observed errors 
The observed variability of CO measurement seen with both techniques having analysed 
the curves by hand was unexpected, however the observed errors seen appear unlikely to 
impact on clinical practice. The bias and wide limits of agreement observed in the 
measurement of MTT by the lithium indicator (Bias -2.8sec, 95% LOA ±5.2sec) highlights 
the problems with this technique using the current equipment configuration and software 
analysis. This error appears to be integral to the measurement of ITBV with the bias and 
LOA (-132ml m-2 [±396ml m-2]) also being considerable. It is worth considering that 
comparison of ITBV, using lithium and the ICG-thermal indicators in the clinical study, 
generated a bias of 407 ml m-2 and LOA±717ml m-2, and whether or not more reliable 
automated curve analysis could have impacted on this analysis to the point of enhancing the 
reliability of the technique. 
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The automated ICG-thermal curve analysis appeared to function adequately for CO, MTT 
and ITBV calculation with acceptable bias and limits of agreement in the clinical setting. 
On the other hand there was considerable observed variability for the measurement of 
ITTV. Consequently there was greater than expected inconsistency in the EVLW volume 
derivation, with potentially clinically significant errors (Bias 0.5ml kg-1, LOA ±1.3ml kg-1). 
It is possible to derive EVLW volume from analysis of the difference between either the 
MTT or Dst of the ICG and thermal curves. Theoretically this time difference should be 
identical if the dye curve analysis is precise. However, it was possible to demonstrate that, 
despite good correlation on linear regression analysis (R2=0.71, p<0.0001), comparison of 
the subsequently derived EVLW volumes resulted in considerable variability (Bias 0.1ml 
kg-1, 95% limits of agreement ±2.4ml kg-1).  It is likely that the observed error is a result of 
problems analysing the downslope of the dye curve, as there was considerable bias and 
limits of agreement comparing PBV and GEDV (PBV bias -65ml, 95% LOA±186ml, 
GEDV bias 162ml, LOA ±266ml). 
 
6.4.3 Conclusions 
Manual lithium indicator dilution curve analysis highlighted that the poor accuracy of MTT 
and consequently ITBV seen in the clinical study may in part be due to the software used to 
analyse the curves. There was also unexpected variability of CO measurement that too may 
be a result of software problems. ICG-thermal dye curve analysis suggested that thoracic 
blood volumes derived from measurement of ICG MTT are reliable, but volumes involving 
analysis of the thermal MTT and downslope times may be inaccurate. 
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Chapter 7 
 Conclusions  
7.1 Summary of findings 
The results of the pilot study were promising and indicated that measuring ITBV by lithium 
indicator dilution should be feasible. Both peri-operative trends and absolute measurements 
of ITBV were consistent with previously published data acquired using indocyanine green 
indicator dilution during and after cardiac surgery with cardio-pulmonary bypass. 
 
The results of the porcine acute lung injury models revealed clinically significant 
differences between EVLW measurements obtained with three in vivo indicator dilution 
techniques and the post-mortem gravimetric method. The Li-thermal and ICG-thermal 
techniques demonstrated acceptable accuracy, but the wide limits of agreement suggested 
poor reliability. The single-thermal technique systematically over-estimated EVLW, with 
unacceptably wide limits of agreement signifying poor reliability.   
 
In post-operative cardiac surgery patients there was poor agreement between measurements 
obtained with both the prototype Li-thermal and the single thermal measurements of 
EVLW volume, and those obtained using the ICG-thermal.  Poor agreement between the 
ICG-thermal and Li-thermal techniques appeared to be due to inaccurate measurement of 
lithium mean transit time using an external sensor attached to a peripheral radial arterial 
catheter. Derived single-thermal EVLW volumes, whilst demonstrating reasonable 
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agreement, showed considerable variability. These findings suggest that trans-pulmonary 
indicator dilution measurements of ITBV and EVLW volume are not sufficiently accurate 
to safely guide clinical interventions in individual critically ill patients regardless of the 
method used.  
 
7.2 Strengths and weaknesses of this work 
Lithium indicator dilution is a proven technology for CO measurement and was compared 
to the standard reference and clinical techniques used for the measurement of EVLW and 
ITBV. All indicator dilution measurements made throughout this research programme were 
performed by the same individual. The cardiac surgical population has been well studied in 
this area with all patients receiving standardised peri-operative care. The study involving 
animal models of acute lung injury were performed in a laboratory with over 20 years of 
experience ensuring the reliability of data collection and the experimental protocol. 
 
Unfortunately, there was a loss of two animals during the gravimetric study. However, 
given the findings, the effect on study power may not have influenced our conclusion. The 
gravimetric technique is not commonly used and the derived data is susceptible to operator 
error despite best efforts. The comparative clinical study suffered irretrievable equipment 
malfunction with the consequential failure to recruit three further patients. Again, given our 
findings the results would appear to still be valid. 
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7.3 Comparison to previous work 
7.3.1 Indicator dilution 
There were two clinical studies in this research programme during which ITBV and EVLW 
volumes were determined. In both studies, measurements of ITBV using lithium indicator 
dilution were consistent with those taken during previous investigations in the cardiac 
surgical population.104,106-108 Direct comparison between studies is not straightforward 
because previous reports present data indexed either according to body mass or surface 
area,  or as absolute values.104,106-108 The peri-operative trends and absolute measurements 
of ITBV in the present studies were consistent with those taken using indocyanine green 
indicator dilution during and after cardiac surgery with cardio-pulmonary bypass.104 
However the comparative ICG-thermal measurements made in the second clinical study did 
not trend as in previous work, nor were the absolute numbers equivalent. This may be due 
to two factors; operator error in obtaining the data, or differences in the fluid management 
of post-op cardiac surgical patients. This may not have been measured appropriately by the 
lithium indicator technique due to the intrinsic problems of MTT measurement and the 
trend in the proof of concept study may have been coincidental. 
 
7.3.2 Gravimetry 
Although considered by some to be the ‘gold standard’, the gravimetric method of EVLW 
volume measurement has some limitations.34,118 Only one post-mortem measurement is 
possible and fluid re-absorption during the interval between death and lung removal may 
affect the accuracy of this method. However, the values obtained were similar to those of 
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previous studies that used the gravimetric technique in models of acute lung injury and 
sepsis 48,61 and greater than those in sham operated animals.61 Similarly, the pre-
intervention ICG-thermal measurements of EVLW volume were consistent with those in 
control animals from a previous study.47  Also in keeping with the current study, this 
previous work suggested that the ICG-thermal dilution technique underestimates EVLW 
volume when compared to gravimetry.47 Such underestimates may be more frequent during 
acute lung injury  or the application of positive end-expiratory pressure.48,51 It is not clear 
why none of the indicator dilution methods proved particularly reliable in comparison to 
gravimetry. In every case, measurements were carefully performed by experienced 
investigators according to the manufacturer’s instructions. Whilst previous comparisons of 
the ICG-thermal and single-thermal methods suggest good agreement with gravimetric 
measurements,45,63 other studies have demonstrated a need for adjustment of the algorithm, 
particularly in laboratory based animal experiments.61,64,122 
 
7.4 General concerns using indicator dilution 
An ideal indicator should meet certain criteria that allow it to be used to determine cardiac 
output and thoracic fluid volumes. These would include uniform distribution throughout the 
physiological compartment under investigation, no loss from the system during passage 
from the point of injection to the site of detection, and being stable, non-toxic and easily 
measured. The indicator should then dissipate rapidly to avoid errors resulting from 
recirculation. Perhaps not surprisingly, the perfect indicator does not exist. The most 
common practical disadvantages include poor stability and difficulties with measurement, 
recirculation or accumulation. Accumulation of the indicator, and concerns regarding 
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potential toxic effects from elevated plasma levels, usually limit the maximum number of 
reliable, safe measurements, although as explained earlier, accumulation and recirculation 
can be potentially overcome by extrapolation of the dilution curve. Hypoxic pulmonary 
vasoconstriction can result in re-distribution of pulmonary blood flow to relatively spared 
regions of the lung, whilst areas of lung with high water content may be under-represented, 
resulting in an underestimate of total EVLW volume.  
 
Of particular concern with the single thermal indicator dilution technique is the loss of the 
thermal signal as the indicator bolus transits the pulmonary compartment. This causes a 
small amplitude dilution curve in comparison to the intravascular indicators, such as ICG or 
lithium, which may compromise the validity of subsequent curve analysis. 
 
Cardiac output measurement error may also result in inaccurate determination of EVLW 
volume by ICG-thermal dilution,53 perhaps explaining the wide limits of agreement seen in 
this programme of research. However the findings of a recent investigation suggest thermal 
indicator loss from oedematous lungs does not affect the accuracy of cardiac output 
measurement by indicator dilution.117 
 
In one report it has been suggested that the ICG-thermal dilution technique may 
underestimate EVLW in comparison with gravimetry.115  This underestimation, which may 
be enhanced during ALI, has been explained by redistribution of pulmonary blood flow 
away from oedematous areas which is thought to prevent indicator diffusion and the 
consequent detection of oedema.47-50 Positive end-expiratory pressure (PEEP) during 
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mechanical ventilation has also been shown to cause underestimation of EVLW volume 
measurement. 51 
 
At present, trans-pulmonary thermal (single) indicator dilution is the only commercially 
available method of EVLW volume measurement at the bedside. This technique involves 
the estimation of ITBV through the assumption of a constant relationship with GEDV. 58 
Whilst this assumption allows a simplified method of EVLW volume measurement using a 
single indicator, there is considerable concern regarding the validity of this approach. 66 
This programme of research also questions the assumptions made by this technique in 
deriving EVLW. 
 
7.5 Suggestions for future work 
The outcomes of this thesis have highlighted the need for further work to establish whether 
the proposed technique of lithium-thermal double indicator dilution for the measurement of 
EVLW volume is feasible. As is not possible to measure a thermal signal using an external 
sensor due to the indicator dilution curve being undetectable, it would appear logical to 
develop a technique using an intravascular catheter sited in a central artery. This would 
then negate the problems observed during this programme of research of measuring ITBV 
using lithium indicator dilution with an external sensor. The simultaneous introduction of a 
thermistor would enable measurement of EVLW volume. Validation with gravimetry in 
animal subjects, then comparative studies in human subjects with ICG-thermal double 
indicator dilution, could verify the accuracy of this proposed technique. It ought then to be 
possible to instigate clinical studies of goal directed therapy, with ITBV and EVLW 
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volume as the targets examining a variety of different clinical outcomes in critically ill 
patients. 
 
7.6 Conclusion 
 
The proposed lithium-thermal double indicator dilution technique for measuring ITBV and 
EVLW is not accurate in its current configuration. Investigation of existing alternative 
technologies compared to gravimetry, the reference technique for EVLW volume 
measurement, suggests double indicator dilution methods are more accurate than the single 
thermal indicator dilution technique. Indeed, this programme of research suggests that 
single thermal indicator dilution is not sufficiently reliable to guide clinical decisions for 
individual patients based on the EVLW volume data acquired with this technique. 
Theoretically lithium indicator dilution will measure ITBV but it appears measurement is 
necessary at a more central artery. Combination with a thermal indicator should allow 
derivation of EVLW volume. As a thermal signal can not be measured using the existing 
external sensor arrangement, an intravascular catheter would need to be developed which 
would generate further research opportunities. 
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IQR   interquartile range 
LOA   limits of agreement 
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